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Abstract 
 
The arrhythmology focuses on the diagnosis and treatment of heart rhythm disorders and 
their complications, and has undergone a dramatic evolution over the past two decades. 
The widespread use of catheter ablation, the introduction of implantable cardioverter 
defibrillators for the prevention of sudden cardiac death and, finally, the development of 
cardiac resynchronization therapy led to a gradual loss of the impact of antiarrhythmic 
drugs as a therapeutic approach. 
This report was performed as a result of an internship performed in Cardiac Physiology 
with the duration of 400 hours. The main goal of the internship was to strengthen 
theoretical knowledge and acquire practical experience in the varied fields of 
arrhythmology, especially in the areas of Cardiac Pacing and Electrophysiology. 
During the internship were performed 41 electrophysiologic studies, where Atrioventricular 
Node Reentrant Tachycardia and Atrial Fibrillation were the most observed arrhythmias. 
New technologies such as three-dimensional mapping for electrophysiology studies are 
developing quickly and being use on a daily basis, as they prove to have safe and higher 
success rates. The proof is that in approximately half of the studies, one of the two 
mapping systems available, Carto or NavX, was used. In addition, were interrogated 283 
pacemakers during the pacing clinics, being the dual chamber with DDD pacing mode the 
most encountered device. A large number of devices with Cardiac Resynchronization 
Therapy and/or Implantable Cardioverter Defibrillators were also observed.  
This report is divided into three chapters. Chapter I is constituted by a revision of the 
literature and includes concepts such as definition and mechanisms of cardiac arrhythmias; 
a brief description of the varied diagnostic tools and its recommendations; and a 
presentation of the different therapeutic approaches available and its indications. The 
second chapter is a descriptive drawing of the activity performed in the modules of 
Electrophysiology and Pacing. Lastly, the chapter III presents two clinical cases in 
Electrophysiology considered interesting from a clinical point of view. 
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Introduction 
 
Arrhythmias are defined as any cardiac rhythm other than the normal sinus rhythm and are 
due to several disorders that alter the rate or rhythm of the heartbeat. These can manifest 
itself in various ways and with a very broad spectrum of severity, ranging from 
asymptomatic until sudden cardiac death.  
Sudden death (SD) is a major public health issue and probably the most challenging issue in 
modern cardiology, taking into account the remarkably high number of SD cases 
(accounting for approximately 100,000 adult deaths in the UK each year – Department of 
Health, 2005) and the important social impact of these events. The incidence of SD 
gradually and significantly increases after 35 - 40 years of age, and is particularly high during 
the acute phase of myocardial infarction (MI). It is also frequent during the chronic phase 
of ischaemic heart disease (IHD), as well as in subjects with any heart disease, especially 
when heart failure (HF) is present. 
The commonest form of cardiac arrhythmia is atrial fibrillation (AF) and this affects 
approximately 3% of the UK population, about 2 million people, and is much more 
common in older subjects. AF affects approximately 4% of the population over 65 years 
old, and 10% of those are older than 80 years. 
The selection of appropriate therapy for the management of cardiac arrhythmias 
necessitates an understanding of the aetiology and mechanism of the arrhythmia, an 
appreciation of the associated medical conditions that may contribute to and/or exacerbate 
the arrhythmia, the risk posed by the arrhythmia, and risk-to-benefit aspects of the selected 
therapy. 
The most commonly therapeutic approach used in the treatment of cardiac arrhythmias 
continues to be held through antiarrhythmic drugs. However, there are a few advances 
made in this area over the past 20 years that have shown these drugs to be less effective 
than previously thought and sometimes pro-arrhythmic.  
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Consequentely, the arrhythmology has undergone a dramatic evolution over the past two 
decades and non-pharmacological treatments have been developed very quickly. The 
widespread use of catheter ablation, the introduction of implantable cardioverter 
defibrillators for the prevention of sudden cardiac death and, finally, the development of 
cardiac resynchronization therapy led to a gradual loss of the impact of antiarrhythmic 
drugs as a therapeutic approach. 
This rapid growth is a consequence of the familiarization of electrophysiological studies, 
which facilitated the understanding of the mechanism of clinical arrhythmias and allowed 
to locate, with great precision, areas within the heart considered critical for its occurrence. 
The interventional laboratories for electrophysiology became important sites for 
therapeutic decisions, with capacity to diagnose, indicate and follow patients with 
arrhythmias eligible for invasive therapy (ablation, pacemaker or implantable cardioverter 
defibrillator). 
The main goal of this internship was to apply scientific and technical knowledge acquired 
during the course in the daily practice and in the clinical context. Therefore, this work 
presents a description of the activity performed during the placement in the areas of 
Cardiac Pacing and Electrophysiology.  
This report is divided into three chapters. Chapter I is constituted by a revision of the 
literature and includes concepts such as definition and mechanisms of cardiac arrhythmias; 
a brief description of the varied diagnostic tools and its recommendations; and also a 
presentation of the different therapeutic approaches available and its indications. The 
second chapter is a descriptive drawing of the activity performed in the modules of 
Electrophysiology and Pacing. Lastly, the chapter III presents two clinical cases in 
Electrophysiology considered interesting from a clinical point of view. 
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Chapter I 
STATE OF THE ART 
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1. CARDIAC ARRHYTHMIAS 
 
Arrhythmias are defined as any cardiac rhythm other than the normal sinus rhythm (SR). 
Sinus rhythm means a stimulus originates in a sinus node and subsequently occurs at 
appropriate rates of conduction transmitted through the atria, the atrioventricular (AV) 
junction and the intraventricular specific conduction system. Therefore, any changes that 
might occur either at the place of the origin of the stimulus or following the normal 
electrical activation of the heart must be considered arrhythmias. 
In adults at rest, the rate of the normal sinus rhythm ranges from 60 to 80 beats per minute 
(bpm). Sinus rhythms over 100 bpm (sinus tachycardia) and under 60 bpm (sinus 
bradycardia) may be considered arrhythmias. However, it should be taken into account that 
sinus rhythm varies throughout a 24 hours period, either sinus tachycardia and sinus 
bradycardia usually are a physiologic response to certain sympathetic (exercise, stress) or 
vagal (rest, sleep) stimuli. Under such circumstances, the presence of these heart rates 
should be considered normal. 
In addition, it is important to remember that: 
1) the term arrhythmia does not specifically mean rhythm irregularity, as regular 
arrhythmias can occur, often with absolute stability (flutter, paroxysmal tachycardia, 
etc.), sometimes presenting heart rates in the normal range, as is the case of atrial 
flutter 4 x 1; 
2) a diagnosis of arrhythmia in itself does not mean evident pathology. In fact, in 
healthy subjects, the sporadic presence of certain arrhythmias, both active 
(premature contractions) and passive (escape complexes, certain degree of AV 
block, evident sinus arrhythmia, etc.) is frequently observed (DE LUNA, 2011). 
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1.1.  CLASSIFICATION 
There are different ways to classify cardiac arrhythmias: 
- according to the site of origin can be divided into supraventricular (including those 
having their origin in the sinus node, the atria, and the AV junction) and ventricular 
arrhythmias; 
- according to the underlying mechanism may be explained by: 
1) abnormal formation of impulses, which includes increased heart automaticity and 
triggered electrical activity; 
2) disturbances of conduction (reentry); 
3) combinations of both. 
- from the clinical point of view may be paroxysmal, persistent or permanent. Regarding 
to tachyarrhythmias, paroxysmal tachyarrhythmias occur suddenly and usually disappear 
spontaneously; persistent tachyarrhythmias are characterized by short and repetitive runs of 
supraventricular or ventricular tachycardia; and permanent tachyarrhythmias are always 
present (i.e. chronic atrial fibrillation); 
- from an electrocardiographic point of view, arrhythmias can be divided into active and 
passive. Active cardiac arrhythmias include isolated or repetitive impulses that command 
heart rhythm, instead of the basic normal sinus rhythm. They are described as isolated 
(premature supraventricular or 
ventricular complexes), 
repetitive (named runs), or 
sustained complexes (different 
types of tachyarrhythmias). On 
the other hand, passive cardiac 
arrhythmias show isolated or 
repetitive sinus or escape 
complexes in an abnormally 
slowed heart rate 
(bradyarrhythmias). This may 
be due to depression of 
automaticity or sinoatrial/AV 
block (DE LUNA, 2011). 
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1.2. MECHANISMS – ESSENCIAL CONCEPTS 
The diagnosis of the underlying mechanism of an arrhythmia can be of great importance in 
guiding appropriate treatment strategies. Spontaneous behaviour of the arrhythmia, mode 
of initiation and termination, and response to premature stimulation and overdrive pacing 
are the most commonly used tools to distinguish among the different mechanisms 
responsible for cardiac arrhythmias. Our present diagnostic tools, however, do not always 
permit unequivocal determination of the electrophysiological mechanisms responsible for 
many clinical arrhythmias or their ionic bases. In particular, it can be difficult to distinguish 
among several mechanisms that appear to have a focal origin with centrifugal spread of 
activation (automaticity, triggered activity, microreentry). This is further complicated by the 
fact that some arrhythmias can be started by one mechanism and perpetuated by another 
(ISSA et al., 2012). Additionally, we should bear in mind that there are modulating factors 
(unbalanced autonomic nervous system, ischemia, ionic and metabolic alterations, stress, 
alcohol and coffee consumption, etc.) that favour the appearance and maintenance of 
arrhythmias (DE LUNA, 2011). 
As referred previously, the mechanisms responsible for cardiac arrhythmias are generally 
divided into categories of disorders of impulse formation (automaticity or triggered 
activity), disorders of impulse conduction (reentry), or combinations of both (PETERS et al., 
2000).  
1.2.1.	  	  	  Automaticity	  
Automaticity is the capacity of some cardiac cells (the automatic slow response cells 
present in the sinus node and to a lesser degree in the atrioventricular node) to not only 
excite themselves but also to produce stimuli that can propagate (Figure 1). Therefore, 
automatic cells excite themselves and produce stimuli that may propagate, whereas 
contractile cells are only excited by a stimulus from a neighbouring cell, transmitting it to 
the nearest cell (domino effect theory). Under normal conditions, contractile cells are not 
automatic cells because they do not excite themselves. However, in specific situations as 
post myocardial infarction or in episodes of myocardial ischemia, the contractile cells may 
develop abnormal automaticity. 
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1.2.2.	  	  	  Triggered	  
Another mechanism that can originate 
arrhythmias due to an abnormal generation of 
stimulus is the triggered activity, characterized 
as an impulse initiation in cardiac fibers caused 
by depolarizing oscillations in membrane 
voltage (known as post-potentials). This is due 
to the presence of early or late post-potentials 
significant enough that their oscillatory 
vibrations initiate a response that may be 
propagated (Figure 2). Early post-potentials 
originate in the beginning of Phase 3 of the 
transmembrane action potential (TAP) before 
repolarization has been completed; late post-
potentials are explained by the presence of 
oscillatory diastolic depolarizations. These seem to be the underlying mechanism of 
arrhythmias such as torsades de pointes or certain arrhythmias caused by digitalis intoxication 
(DE LUNA, 2011). 
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Figure 1. Sinus node transmembrane action 
potential (A) transmitted to the atrioventricular 
junction (B), the ventricular Purkinje (C) and 
ventricular muscle (D). 
Figure 2. The presence of early (A-C) and late (D and E) post-potentials is the 
mechanism addressing the occurrence of early stimuli (complexes) due to triggered 
activity. 
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1.2.3.	  	  	  Reentry	  
Reentry occurs when a propagating action potential wave fails to extinguish after initial 
tissue activation; instead, it blocks in circumscribed areas, circulates around the zones of 
block, and reenters and reactivates the site of original excitation after it recovers 
excitability. Reentry is the likely mechanism of most recurrent clinical arrhythmias (ISSA et 
al., 2012). For this phenomenon to exist three conditions are necessary: 
a) the presence of a circuit (through which the stimulus may circulate/reenter); 
b) an unidirectional block in part of the circuit (where the stimulus may be conducted 
in one direction only); 
c) an appropriate conduction velocity (the conduction velocity must be slow to 
improve the probability that all segments of the circuit are out of the refractory 
period when the reentrant stimulus reaches them). 
 
The ectopics play an important role in the onset of reentries, once a premature impulse is 
much more likely to find myocardial fibers at different stages of refractory periods’ 
recovery and therefore activate a reentrant circuit (DE LUNA, 2011). 
The reentrant circuit can occur in different locations of the heart. It can be initiated in a 
small area (micro-reentry); be located in more extensive areas of the ventricle or through 
the specific intraventricular conduction system; be macro-circuits localized preferably in the 
right atrium causing typical or atypical flutter; and involve the AV junction. 
 
A circuit comprising the AV junction exclusively. 
It was previously believed that this circuit was functional and located within the AV node 
(intranodal). It was presumed that the AV node had a longitudinal dissociation, with a slow 
conduction tract (α) and fast conduction tract (β) (Figure 3). Now it is known (Wu and 
Yeh, 1994; Katritsis and Becker, 2007) that these circuits have an anatomic basis in which 
tissue of the lower atrium is also involved (AV junction). This results in several possible 
circuits accounting for the different types of reentrant tachycardias with exclusive 
involvement of the AV junction structures, however there are two main types: 
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Slow-fast type: constitute approximately 50% of paroxysmal tachycardias involving the 
AV junction (Atrioventricular Nodal Reentrant Tachycardia, AVNRT). In a few cases, the 
tachycardia is due to the abnormal generation of stimuli. In 
the case of an AVNRT, a premature stimulus (atrial 
premature contraction) is blocked in the fast pathway (β) 
still in the absolute refractory period (ARP). It may go 
through the α pathway with a shorter refractory period, 
albeit with a lower conduction velocity. As a result, this 
stimulus is conducted to the ventricles with a longer P′R 
than the baseline PR interval. At some point as the fast 
pathway (β) is out of the refractory period, the premature 
stimulus retrogradely invades this pathway and rapidly 
reaches the atrium (P′), while at the same time entering 
again into the slow pathway (α), and is conducted to the 
ventricles to generate the QRS-2 complex (2 in Figure 4). 
Conduction to the atrium is very fast, and the ectopic P′ is 
concealed in the QRS complex or stuck at the end of it, 
simulating an “S” or “r” wave. 
Fast-slow type: is much less frequent. The episodes are incessant and non-paroxysmal. It 
was thought to imply an inverted AV junctional circuit, with a stimulus going down 
through the fast pathway and slowly up through the slow pathway. Currently, there are 
some suggestions that this type of tachycardia uses a circuit in which an anomalous bundle 
takes part; the stimulus is anterogradely conducted through the pathway and is retrogradely 
conducted through an anomalous pathway with long conduction times (DE LUNA, 2011). 
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Figure 4. Example of slow-fast 
tachycardia with exclusive 
involvement of the AV junction, 
initiated by an atrial ectopic. 
Figure 3. Example of a reentrant 
tachycardia involving the AV junction 
only. The premature atrial ectopic (AE), 
which does not undergo anterograde 
conduction on the β pathway, is 
conducted through the α pathway. 
Then, it facilitates a reentry through the 
β pathway, with fast atrial retrograde 
activation (P′), which may be concealed 
within or at the end of the QRS 
complex (it may mimic an r′ or S wave). 
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1.3. EPIDEMIOLOGY  
Sudden death (SD) is a major public health issue and probably the most challenging issue in 
modern cardiology, taking into account the remarkably high number of SD cases 
(accounting for approximately 100,000 adult deaths in the UK each year – Department of 
Health, 2005) and the important social impact of these events. In addition, cardiovascular 
disease (CVD) is the leading cause of mortality in the UK, and was responsible for over 
50,000 premature deaths in 2006.  
The incidence of SD gradually and significantly increases after 35 - 40 years of age, and is 
particularly high during the acute phase of myocardial infarction (MI). It is also frequent 
during the chronic phase of ischaemic heart disease (IHD), as well as in subjects with any 
heart disease, especially when heart failure (HF) is present. Acute IHD is frequently 
associated with SD in adults. In the majority of cases of SD outside acute IHD or 
channelopathies, HF, or at least left ventricular systolic dysfunction (LVSD), is present. HF 
may be idiopathic or present in patients with chronic IHD, hypertension, 
cardiomyopathies, etc. (DE LUNA, 2011). 
The incidence and prevalence of heart failure increase steeply with age, and the average age 
at first diagnosis is 76 years old. The incidence of heart failure in the UK is 140 per 100,000 
men and 120 per 100,000 women. Although the incidence is higher in men, evidence 
suggests higher mortality in women with the condition. Around 3% of people aged 65–74 
years have heart failure; this increases to about 7% of those aged 75–84 years, and to just 
over 14% in those aged 85 years and older. The prevalence of heart failure in the UK is 40 
per 1000 in men and 30 per 1000 in women (ARONSON et al., 2010). 
About 1% of emergency hospital admissions amongst adults are primarily due to heart 
failure, which contributes to a further 4%, although these may be underestimated due to 
issues with diagnosis and case definition. In the EuroHeart Failure survey, 36% of those 
who had left ventricular function assessed, had an left ventricular ejection fraction (LVEF) 
≤ 35% and, of these, 41% had a QRS duration ≥120 ms; 7% had right bundle branch 
block (RBBB), 34% had left bundle branch block (LBBB) or other intraventricular 
conduction delay (IVCD) and 17% had RS ≥150 ms. In the Italian Network on CHF (IN-
CHF) registry, 391 patients (25%) had complete LBBB, 336 (6%) had complete BBB and 
339 (6%) had other forms of IVCD. The annual incidence of LBBB is about 10% in 
ambulatory patients with left ventricular systolic dysfunction and chronic HF (BRIGNOLE et 
al., 2013). 
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Arrhythmias may manifest itself in various ways and in a very broad spectrum of severity. 
The commonest form of cardiac arrhythmia is atrial fibrillation (AF). This affects 
approximately 3% of the UK population, about 2 million people, and is much more 
common in older subjects. AF affects approximately 4% of the population over 65 years 
old, and 10% of those are older than 80 years. Most patients with AF are treated with 
tablets alone but in patients with AF who have troublesome symptoms despite medication, 
ablation has been recommended. Prospective and randomised studies have shown a clear 
reduction in symptoms from ablation therapy compared with medication alone. 
Furthermore, ablation therapy has been shown to be cost effective for these patients 
(MCKENNA et al., 2009; CAMM et al., 2010). Furthermore, supraventricular tachycardias 
(SVT) affects over 200,000 people in the UK and most commonly presents between the 
age of 10 and 50 years. 
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2. DIAGNOSTIC TOOLS 
 
The clinical management of patients with arrhythmias or suspicion of them should begin 
with a history taking and a physical examination. 
The history taking should include a careful examination to seek symptoms suggestive of 
arrhythmias, palpitations, dizziness, syncope or pre-syncope, but also angina or heart 
failure. Note that not all patients with arrhythmias are symptomatic and that some 
symptoms, such as palpitations, does not always correspond to arrhythmias. 
The physical examination of patients with arrhythmias has three main goals:  
1) Distinguish diagnostic elements of the arrhythmia itself; 
2) Assess the hemodynamic consequences of the arrhythmia;  
3) Diagnose a possible underlying heart disease or precipitating factors, such as 
hyperthyroidism, alcoholism ("Holiday Heart Syndrome", originally described by 
Ettinger et al, 1978), etc. 
 
Palpitations are the most common symptom that causes the patient to seek medical help. It 
is defined as the perception of a heartbeat and is described by patients as an unpleasant 
sensation of heartbeat in chest and/or adjacent areas. The characteristics of palpitations 
must always be investigated: if they are associated with chest pain, either during rest or 
exercise; if they occur in the supine or standing position; if they occur after certain 
predisposing factors such as emotional stress or alcohol intake; the onset and termination 
of the episode (abrupt or gradual); if the beats are regular or irregular; the episode duration 
(short or long) and if symptoms existed prior to the episode or are associated with syncope 
or fainting (RAVIELE et al., 2011). The presence of syncope when related with arrhythmias 
suggests the existence of a severe arrhythmia. This may correspond to a paroxysmal AV 
block or ventricular/supraventricular tachyarrhythmia. 
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A brief description of the symptoms most of the times allow to make a preliminary 
diagnosis and determine the severity of the arrhythmia. However, sometimes a patient 
describes a change in the heart rhythm suggestive of an arrhythmia, but nothing appears on 
the electrocardiogram (ECG) trace, even if an arrhythmia is detected during the physical 
examination.  
Therefore, it becomes important to integrate the family history, physical examination 
results and surface ECG with other special electrocardiographic techniques (Exercise 
Tolerance test, Holter or 24 hour tape, Electrophysiological study) and imaging techniques 
(Echocardiography, Cardiac MRI, Cardiac CT and Coronarography), as well as genetic 
tests, to reach a correct diagnosis, to determine the patient’s prognosis, and to be able to 
take the most appropriate therapeutic decision. 
It is important to emphasize the value of extensive electrocardiographic knowledge, as 
minor changes (i.e. of repolarization) such as the presence of negative T waves in leads V1 
to V3–V4 in the case of Arrhythmogenic Right Ventricular Dysplasia (ARVD), or a slight 
ST segment elevation with r’, usually seen in lead V1 in the case of Brugada Syndrome, may 
be essential to suggest a diagnosis. 
 
2.1. RESTING ELECTROCARDIOGRAM 
The diagnosis of arrhythmias is done via additional diagnostic tests, being the ECG the 
first exam to take place, once is the most affordable. Identifying the presence of P waves, 
the QRS morphology and the relationship between both, the rate and regularity of the 
heart rhythm, may be the only information needed to accurately diagnose the arrhythmia 
(O'ROURKE et al., 2002). 
Furthermore, a standard resting 12 lead ECG also allows the identification of various 
congenital abnormalities associated with ventricular arrhythmias and sudden cardiac death 
(SCD) {e.g., Long QT Syndrome (LQTS), Short QT Syndrome (SQTS), Brugada 
Syndrome, ARVD}; the identification of many other parameters, such as those due to 
electrolyte disturbances; or evidence suggesting underlying structural disease, such as 
bundle branch block, AV block, left ventricular hypertrophy (LVH) and Q waves indicative 
of ischemic heart disease or infiltrative cardiomyopathy. QRS duration and repolarization 
abnormalities are both independent predictors of SCD. A prolonged QRS duration greater 
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than 120 to 130 ms has been shown in a number of studies to be associated with increased 
mortality in patients with a reduced LVEF (equal to or less than 30%). Prospective studies 
have also reported an association between ST segment depression or T wave abnormalities 
and increased risk of cardiovascular death and SCD in particular (ZIPES et al., 2006). 
Carotid sinus massage with electrocardiographic recording may also help us in the 
differential diagnosis of the different types of tachyarrhythmias, according to the results of 
this manoeuvre. 
On some occasions, however, conventional surface electrocardiography cannot confirm an 
arrhythmia suggested by history taking or physical examination, or it cannot confirm the 
correct diagnosis (DE LUNA, 2011). 
 
2.2. AMBULATORY ECG 
The use of continuous or intermittent ambulatory recording techniques can be very helpful 
in diagnosing a suspected arrhythmia, establishing its frequency, and relating symptoms to 
the presence of the arrhythmia. Silent myocardial ischemic episodes may also be detected 
(ZIPES et al., 2006). 
The 24 hour tape recording for prolonged periods of daily living was introduced in 
cardiology in 1961 by Norman J. Holter. Its introduction allowed to make the diagnosis 
and characterization of cardiac arrhythmias; to obtain an objective correlation between 
symptoms and the presence or absence of arrhythmias; quantify and classify the severity, 
identify the mechanisms and conditions; and also assess the therapeutic efficacy of 
antiarrhythmic drugs. 
The devices for ambulatory ECG monitoring may be divided into two main categories: 
external and implanted. External devices include Holter recorder - indicated for review of 
arrhythmias and symptoms with a daily frequency; and cardiac loops – for recording of 
events triggered by the patient or self-activated for a period of more than two weeks in 
situations where the frequency of symptoms occurs weekly. On the other hand, 
implantable loop recorders, a subcutaneous implantable device, are suitable for situations 
where the frequency of symptoms is monthly or more. These devices are capable of 
monitoring the rhythm and logging events triggered by the patient and self-activated events 
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and although it requires surgical implantation, they have been shown to be extremely useful 
in diagnosing serious tachyarrhythmias and bradyarrhythmias in patients with life-
threatening symptoms such as syncope (ZIPES et al., 2006). Pacemakers and Implantable 
Cardioverter Defibrillators (ICD) are also included in the category of implantable devices 
and provide important information through the diagnostic functions and intracavitary 
electrograms (IEGM) that are stored in the internal memory (RAVIELE et al., 2011). 
Nowadays, due to the high technological evolution established either regarding the 
recorders or the analysis systems, 24 hour tapes provide even additional information such 
as: ST segment analysis, Heart Rate Variability (HRV), QT interval dispersion and late 
potentials, which provides prognostic information for the respective arrhythmia. 
 
Recommendations of Class I (ZIPES et al., 2006): 
1) Ambulatory ECG is indicated when there is a need to clarify the diagnosis by 
detecting arrhythmias, QT interval changes, T-wave alternans (TWA), or ST changes; 
to evaluate risk, or to judge therapy (Level of Evidence A); 
2) Event monitors are indicated when symptoms are sporadic, to establish whether 
or not they are caused by transient arrhythmias (Level of Evidence B); 
3) Implantable recorders are useful in patients with sporadic symptoms suspected to 
be related to arrhythmias such as syncope when a symptom-rhythm correlation 
cannot be established by conventional diagnostic techniques (Level of Evidence B). 
 
2.3. EXERCISE TOLERANCE TEST 
The exercise tolerance test (ETT) is useful for the evaluation of exercise-induced 
arrhythmias, particularly ventricular ectopy and tachyarrhythmias; to evaluate ischemic 
heart disease, sinus or AV node dysfunction and also to assess the proarrhythmic effects 
(heart rate dependent) of antiarrhythmic drugs. The exercise tolerance test can also be used 
to estimate the refractory period of the accessory pathway (AP) in patients with Wolff-
Parkinson-White (WPW) syndrome: its disappearance with effort can be a benign sign as 
may be indicative of a refractory period higher than 250 ms and therefore, with low risk. In 
patients with IHD, myocardial ischemia induced by exercise can precipitate the onset of 
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monomorphic ventricular tachycardia (VT), polymorphic or even ventricular fibrillation 
(VF). 
The ETT is also valuable for evaluating patients with symptoms suggestive of arrhythmias 
triggered by exercise such as idiopathic ventricular tachycardia in patients with 
Arrhythmogenic Right Ventricular Dysplasia, Torsades de Pointes secondary to long QT 
syndrome, or Catecholaminergic Polymorphic ventricular tachycardia (CPVT) (O'ROURKE 
et al., 2002). 
 
Recommendations of Class I (ZIPES et al., 2006): 
1) Exercise testing is recommended in adult patients with ventricular arrhythmias 
who have an intermediate or greater probability of having CHD by age, gender, and 
symptoms to provoke ischemic changes or ventricular arrhythmias (Level of 
Evidence B); 
(2) Exercise testing, regardless of age, is useful in patients with known or suspected 
exercise-induced ventricular arrhythmias, including catecholaminergic VT, to 
provoke the arrhythmia, achieve a diagnosis, and determine the patient’s response to 
tachycardia (Level of Evidence B). 
 
2.4. IMAGING TECHNIQUES 
2.4.1.	  	  	  Transthoracic	  Echocardiogram	  
Echocardiography is the imaging technique that is most commonly used because it is 
inexpensive in comparison with other techniques such as Magnetic Resonance Imaging 
(MRI) and Cardiac Computed Tomography (CT), it is readily available, and it provides 
accurate diagnosis of myocardial, valvular, and congenital heart disorders associated with 
ventricular arrhythmias and SCD (Table 2). In addition, LV systolic function and regional 
wall motion can be evaluated and, in a majority of patients, ejection fraction (EF) can be 
determined. The combination of echocardiography with exercise or pharmacological stress 
(commonly known as ‘stress echo’) is applicable to a selected group of patients who are 
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suspected of having ventricular arrhythmias triggered by ischemia and who are unable to 
exercise or have resting ECG 
abnormalities that limit the 
accuracy of ECG for ischemia 
detection. Anomalous origin of 
coronary arteries can be 
detected by echocardiography 
or other imaging techniques 
(ZIPES et al., 2006). 
 
Recommendations of Class I (ZIPES et al., 2006): 
1) Echocardiography is recommended in patients with ventricular arrhythmias who 
are suspected of having structural heart disease. It is also recommended for the 
subset of patients at high risk for the development of serious ventricular arrhythmias 
or SCD, such as those with dilated, hypertrophic, or right ventricle (RV) 
cardiomyopathies, acute myocardial infarction (AMI) survivors, or relatives of 
patients with inherited disorders associated with SCD (Level of Evidence B); 
2) Exercise testing with an imaging modality (echocardiography or myocardial 
perfusion [single-photon emission computed tomography (SPECT)]) is 
recommended to detect silent ischemia in patients with ventricular arrhythmias who 
have an intermediate probability of having IHD by age, symptoms, and gender and 
in whom ECG assessment is less reliable because of digoxin use, LVH, greater than 
1mm ST segment depression at rest, WPW syndrome and LBBB; or are physically 
unable to perform a symptom limited exercise test (Level of Evidence B).  
 
2.4.2.	  	  	  Magnetic	  Resonance	  Imaging	  
Advances in cardiac MRI have made possible the use of this imaging technique to evaluate 
both the structure and function of the beating heart. The excellent image resolution 
obtained with current techniques is suitable for an accurate quantification of chamber 
volumes, LV mass, and ventricular function. This is of particular value to patients with 
Table 2. Conditions associated with ventricular arrhythmias that 
can be diagnosed with echocardiography.  
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suspected arrhythmogenic RV dysplasia, in whom MRI provides excellent assessment of 
RV size, function, and regional wall motion and, importantly, may allow the detection of 
fatty infiltration within the RV myocardium (RV angiography may also be useful in these 
cases). Cardiac MRI is increasingly being applied and validated for the detection of 
ischemia (adenosine stress perfusion and dobutamine stress wall motion studies) and for 
the detection and quantification of infarction/fibrosis, a substrate for VT. The cost and 
availability of cardiac MRI are becoming more competitive. Cardiac MRI can provide a 
comprehensive cardiac evaluation in a single study. 
  
Recommendation of Class IIa (ZIPES et al., 2006): 
1) Magnetic Resonance Imaging can be useful in patients with ventricular 
arrhythmias when echocardiography does not provide accurate assessment of LV 
and RV function and/or evaluation of structural changes (Level of Evidence B). 
 
2.4.3.	  	  	  Cardiac	  Computed	  Tomography	  
The same way as MRI, the field of CT has advanced greatly with the development of fast 
scanners with better resolution that allow tomographic imaging of the heart and coronary 
arteries. These systems allow precise quantification of LV volumes, EF, and LV mass with 
results comparable to MRI but, in addition, provide segmental images of the coronary 
arteries from which the extent of calcification can be quantified. Cardiac CT can also be 
used in selected patients in whom evaluation of cardiac structures is not feasible with 
echocardiography and when MRI is not available. Currently, there is no incremental clinical 
benefit derived from imaging the coronary arteries by cardiac CT in patients with 
ventricular arrhythmias. 
 
Recommendation of Class IIa (ZIPES et al., 2006): 
1) Cardiac Computed Tomography can be useful in patients with ventricular 
arrhythmias when echocardiography does not provide accurate assessment of LV 
and RV function and/or evaluation of structural changes (Level of Evidence B). 
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2.5. ELECTROPHYSIOLOGY STUDY 
Electrophysiology studies (EPS) for the evaluation of VT were introduced in 1972 by 
Wellens et al. In the recent years though, has been converted into an important clinical tool 
for the diagnosis and treatment of many arrhythmias, especially when information provided 
by electrocardiography and other non-invasive diagnostic tests are not enough.  
The placement of electrocatheters in many and varied intracardiac points allows you to 
map the sequence of activation in the atria, AV junction and ventricles; locate the crossing 
points of the accessory pathways; situate the place of origin of arrhythmias; understand the 
mechanisms of supraventricular and ventricular tachyarrhythmias as well as evaluate the 
efficiency of the antiarrhythmic therapy. In summary, the indications for EP studies are: 
document the inducibility of VT; guide ablation; evaluate drug effects; assess the risks of 
recurrent VT or SCD; evaluate loss of consciousness (LOC) in selected patients with 
arrhythmias suspected as a cause; assess the indications for ICD therapy. 
 
The yield of EP varies fundamentally with the kind and severity of the underlying heart 
disease, the presence or absence of spontaneous VT, concomitant drug therapy, the 
stimulation protocol, and the site of stimulation. Highest induction rates and 
reproducibility are observed in patients after MI. To evaluate patients with ventricular 
arrhythmias, most centres use 6 to 8 ventricular stimuli at drive cycle lengths (CL) between 
600 and 400 ms at the RV apex, at twice diastolic threshold and the pulse duration of 0.5 to 
2.0 ms, delivering 1 to 3 ventricular extrastimuli at baseline. This test may be repeated 
during isoprenaline infusion. The prematurity of extrastimuli is increased until 
refractoriness or induction of sustained ventricular tachyarrhythmia is achieved. Long-short 
cycle sequences may be tested. Because premature ventricular stimulation with a very short 
coupling interval is more likely to induce VF as opposed to monomorphic VT, it may be 
reasonable to limit the prematurity of the extrastimuli to a minimum of 180 ms when 
studying patients for whom only inducible sustained monomorphic VT would be 
considered a positive endpoint. EP testing may be repeated at the RV outflow tract 
(RVOT) or LV. In some patients with rate-dependent induction of VT, rapid atrial or 
ventricular stimulation may induce VT (ZIPES et al., 2006). 
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Recent advances in technology have enabled mapping systems to: 
a) display three-dimensional representation of cardiac chambers; 
b) provide a visual display of the arrhythmia activation sequence; 
c) display the arrhythmia substrate, e.g. scars, areas of conduction block; 
d) non-fluoroscopically navigate catheters in real-time; 
e) annotate sites of ablation lesions. 
Three-dimensional mapping also provides an opportunity to elucidate the substrate of an 
arrhythmia. Mapping of electrogram voltage and local excitability helps to delineate areas of 
interest including potential scar or channels of conduction in reentry circuits. The systems 
that are most commonly used in clinical practice include sequential site mapping using 
magnetic field (Carto) or electrical field (NavX) guidance. 
 
CARTO (BIOSENSE WEBSTER,  INC)  ELECTROANATOMICAL MAPPING SYSTEM 
The Carto system uses ultra-low magnetic fields to localize a specialized ablation catheter 
(Navistar) that contains a 
magnetic sensor at the distal 
electrode (Figure 5). These 
magnetic fields are generated by 
three coils mounted under the 
examination table (Figure 6). 
The three-dimensional position 
and orientation (pitch, roll and 
yaw) of the catheter tip can be 
determined. 
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Figure 5. CARTO electroanatomical map setup. The three 
hemispheres represent fields from the three different 
electromagnets situated beneath the patient. The catheter tip 
contains an element that is sensed by these fields, and this 
triangulating information is used to monitor the location and 
orientation of the catheter tip in the heart.  
Figure 6. Illustration of the three coils 
mounted under the examination table. 
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The Navistar catheter then collects electrical data sequentially from one or more cardiac 
chambers of interest. The system constructs a 3D geometric “shell” representing the shape 
and size of the chamber. Electroanatomic data can be shown in a number of ways: Local 
activation time (LAT) map (Figure 7); Isochronal map; Propagation map; Voltage map; 
Mesh map and Complex fractioned atrial electrograms. 
 
Advantages of this system: 
- Geometry construction and annotation of sites of interest are accurate and intuitive; 
- Electrical data and anatomic locations are collected and displayed by the system 
simultaneously during construction of the chamber geometry; 
- Respiratory motion artefacts are relatively limited; 
- LAT maps can be superimposed on a substrate map (e.g. scar); 
- The algorithm is suitable for generating endocardial and epicardial anatomic maps. 
 
Like any other imaging technique, this system also carries some limitations: 
- Sequential site mapping can be time-consuming; 
- Mapping of non-sustained tachycardia may be very difficult; 
- Arrhythmias that are not well tolerated hemodynamically are usually not mappable; 
- A change in tachycardia cycle length or morphology requires new mapping of the 
chamber (BASHIR et al., 2010). 
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Figure 7. Right atrial electro-
anatomical activation map in a 
patient with prior atrial tachycardia 
following atrial septal defect repair 
years before. The view is from the 
aspect of the right rib margin 
(upward toward the lateral right 
atrium). A, The activation pattern 
suggests a focal process with 
centrifugal spread of activation from 
the central red area. B, With 
additional detailed mapping below 
the red area, a return path for a 
reentrant circuit is evident.  
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ENSITE NAVX (ST.  JUDE MEDICAL)  NAVIGATION SYSTEM 
The Ensite NavX system (Figure 8) generates a 
transthoracic electrical field by three pairs of 
orthogonal cutaneous patches. Catheter location can 
be determined by measuring the local voltage 
gradient along each axis with respect to a reference 
electrode. Sequential positioning of a conventional 
catheter along the endocardial surface defines the 
geometry of a cardiac chamber. Separate geometries 
can be constructed for vessels attached to the 
chamber. The mapping catheter then collects 
electrical data and the system sequentially displays 
the information onto the geometry. Electroanatomic 
data can be shown in many ways: diagnostic 
landmarking tool; voltage mapping and Complex 
fractioned atrial electrograms mapping (as in Carto 
system). 
 
Advantages: 
- Multi-polar catheters may be used to 
simultaneously collect electroanatomical data from 
multiple sites at the same time; 
- Catheter navigation is fast and responsive; 
- Any conventional mapping catheter may be used, 
thus reducing costs; 
- Any energy source may be used for ablation; 
- Multiple chamber mapping can be performed. 
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Figure 8. The NavX system. A, Left anterior oblique view of four standard diagnostic catheters 
(positioned in the high right atrium [HRA], His bundle [HIS], right ventricular [RV] apex, and 
coronary sinus [CS]) and a standard ablation catheter (Abl). B, Virtual anatomical geometry of the 
RA is acquired by moving the catheter in all directions throughout the chamber of interest. C, 
Color-coded activation map superimposed on the RA 3D geometry localizing the origin of the 
atrial tachycardia to the triangle of Koch between the His bundle, coronary sinus ostium (CSO) 
and tricuspid valve (TV). 
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Limitations: 
- Chamber surface interpolations (“false space” without collected points) can occur 
in complex geometries; 
- Catheter navigation accuracy can be affected by changes in respiratory patterns in a 
conscious patient; 
- Mapping of non-sustained or poorly tolerated tachycardia may be difficult; 
- Changes in tachycardia cycle length or morphology requires repeat sequential 
mapping of the tachycardia circuit (BASHIR et al., 2010). 
 
 
Recommendations of Class I (ZIPES et al., 2006): 
1) EP is recommended for diagnostic evaluation of patients with remote MI with 
symptoms suggestive of ventricular tachyarrhythmias, including palpitations, 
presyncope, and syncope (Level of Evidence B); 
2) EP is recommended in patients with CHD to guide and assess the efficacy of VT 
ablation (Level of Evidence B); 
3) EP is useful in patients with CHD for the diagnostic evaluation of wide QRS 
complex tachycardias of unclear mechanism (Level of Evidence C); 
4) EP is recommended in patients with syncope of unknown cause with impaired LV 
function or structural heart disease (Level of Evidence B). 
 
Recommendation of Class IIa (ZIPES et al., 2006): 
5) EP can be useful in patients with syncope when bradyarrhythmias or 
tachyarrhythmias are suspected and in whom non-invasive diagnostic studies are not 
conclusive (Level of Evidence B). 
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3. THERAPEUTIC APPROACH 
 
The selection of appropriate therapy for the management of cardiac arrhythmias 
necessitates an understanding of the aetiology and mechanism of the arrhythmia, an 
appreciation of the associated medical conditions that may contribute to and/or exacerbate 
the arrhythmia, the risk posed by the arrhythmia, and risk-to-benefit aspects of the selected 
therapy. Management of the manifest arrhythmia may involve discontinuation of offending 
proarrhythmic drugs, specific antiarrhythmic therapy with drugs, implantable devices, 
ablation or surgery (ZIPES et al., 2006).  
The most commonly therapeutic approach used in the treatment of cardiac arrhythmias 
continues to be held through antiarrhythmic drugs. However, there are a few advances 
made in this area over the past 20 years that have shown these drugs to be less effective 
than previously thought and sometimes pro-arrhythmic. Thereafter, non-pharmacological 
treatments have been developed very quickly and there are many centres where this form 
of therapy is already being used on a daily basis, especially in patients with tachycardic 
syndromes. This rapid growth is a consequence of the familiarization of 
electrophysiological studies, which facilitated the understanding of the mechanism of 
clinical arrhythmias and allowed to locate, with great precision, areas within the heart 
considered critical for its occurrence. 
At the moment there are three main types of therapeutic available: surgical ablation, 
catheter ablation and implantable devices (PM, ICD and CRT). Its applications as well as 
the results obtained depend primarily on the type of the arrhythmia. 
It is also important to mention that procedures with ablation (surgical and via catheter) 
were designed to be "curative", while implantable devices were not designed to prevent the 
occurrence of tachycardia but to stop it quickly (when able to). For this reason, the patient 
needs to continue on antiarrhythmic drug therapy and often feel the onset of seizures. 
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These implantable devices are therefore "palliative" procedures rather than “curative”, 
however depending on each case, it might be the best treatment option. 
In order to obtain a successful outcome in the treatment of arrhythmias, it is important to 
treat the underlying pathology with optimal therapy for heart failure, correction of 
hemodynamic and electrolyte disturbances and optimized treatment of ischemic heart 
disease. There is also a reasonable likelihood of coronary revascularization reducing the 
frequency and complexity of arrhythmias, and in some patients even eliminates these 
arrhythmias. These options can reduce the symptoms of arrhythmias and specially reduce 
total and arrhythmic mortality (ZIPES et al., 2006). 
We will now present a brief description of the different non-pharmacological therapeutic 
approaches available: Cardiac Pacing, Implantable Cardioverter Defibrillator, Cardiac 
Resynchronization Therapy (CRT) and Radiofrequency Ablation. 
 
3.1. CARDIAC PACING 
The earliest demonstration of temporary pacing of the heart  was provided by Mark C. 
Lidwill in the 1920s. Dr. Lidwill developed a portable piece of electrical equipment that was 
meant to provide temporary pacing in the event of an emergency during a surgical 
procedure.  There was little further progress in development of pacing until the 1950s. 
Shortly thereafter, in 1954, Electrodyne came out with a commercial version of an external 
pacemaker, which became widely used throughout the hospitals for the emergency 
resuscitation of patients with asystole. In 1958, it was firstly described by Furman and 
Robinson the temporary pacing stimulation via peripheral venipuncture, allowing an 
immediate treatment for patients with severe bradyarrhythmia (2nd degree AV block Mobitz 
II; 3rd degree AV block; severe bradycardia) and/or hemodynamic instability. While these 
results were gratifying, external pacemakers were only practical for temporary use. It 
quickly became apparent that chronic pacing would best be achieved with a totally 
implantable system. 
The first permanent pacemaker was implanted by Dr. Ake Senning in Sweden in 1958 in a 
patient named Arne Larsson. It was a totally implantable system that used an epicardial lead 
on the ventricle. Mr. Larsson actually had 26 pacemakers throughout his life. His story 
provides an excellent testimonial to the success of permanent pacing since after having 
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suffered from multiple daily syncopal spells just before he received his first pacemaker, 
went on with a productive life, until he died in 2001 at the age of 86 (CURTIS, 2010). 
 
 
 
 
 
 
 
 
Since its first establishment to the present day, cardiac pacing has gone through 
tremendous technological advances, either in software or hardware wise, being the primary 
goal an appropriate electric correction of the heart rate and the underlying conduction 
disorders, in order to simulate as best as possible the sinus node and to meet the needs of 
the patient, while minimizing the side effects. Moreover, is proved to be effective in 
improving the quality of life and to decrease the mortality and morbidity. 
Between the varied components of the cardiac pacing that has been suffering huge 
developments (batteries, electrodes, materials, surgical techniques), we draw the attention 
for the advances in microelectronics, which have converted the pacemaker in a smart 
intelligent device, capable of performing a variety of “physiological” functions, adaptable to 
different clinical situations.  
The electrical therapy with implantation of permanent pacemaker (PPM) is indicated in 
several clinical scenarios, including situations of bradyarrhythmia and/or symptomatic 
tachyarrhythmia (EPSTEIN et al., 2008). 
The establishment of consensus criteria and guidelines in order to standardize the 
indications for permanent pacemaker implantation has shown a significant contribution in 
the search for the best cost-benefit ratio. Thus, recommendations for cardiac pacing and 
device therapy is periodically updated, either regarding conventional indications (sick sinus 
syndrome, AV block and carotid sinus hypersensitivity) or the inclusion of new indications 
related to clinical entities susceptible of cardiac pacing as therapy (heart failure, vasovagal 
syncope, paroxysmal atrial fibrillation, hypertrophic obstructive cardiomyopathy). 
Figure 9. Major milestones in cardiac pacing. 
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SICK SINUS SYNDROME 
The sinus node dysfunction is characterized by electrocardiographic and 
electrophysiological disorders involving the sinus node and its electrical connections, which 
is often the result of chronic fibrotic degeneration or calcification of the sinus node and/or 
the surrounding atrial tissues. The association of symptoms related to these disorders is 
called sick sinus syndrome (SSS). May be manifested by 3 different rhythm disorders:  
1) benign sinus bradycardia or sinus pauses; 
2) tachyarrhythmias - as paroxysmal AF, atrial flutter, atrial tachycardia (AT) and 
supraventricular tachycardia; 
3) Bradi/tachycardia - alternating slow and fast rhythms. 
The most serious symptom of SSS is the syncope or presyncope. 
 
Indication of Class I (EPSTEIN et al., 2008): 
1) PPM is indicated for sinus node dysfunction with documented symptomatic 
bradycardia, including frequent sinus pauses that produce symptoms; for 
symptomatic chronotropic incompetence and for symptomatic sinus bradycardia that 
results from required drug therapy for medical conditions (Level of Evidence C). 
Indication of Class IIb (EPSTEIN et al., 2008): 
2) Dual chamber PM is recommended in SSS with minimization of RV pacing, in 
order to avoid changes that may lead to desynchronization of the ventricles resulting 
in ventricular pacing from the RV apex pacing (Level of evidence C). 
 
 
ACQUIRED ATRIOVENTRICULAR BLOCK 
Atrioventricular block may require PM therapy for prognostic reason and pacing may be 
indicated in asymptomatic patients. 
In first degree AV block, cardiac pacing is not recommended unless the PR interval is 
unable to adapt to the heart rate during exercise and is sufficiently long (usually> 300 ms) 
to cause symptoms (Class IIa; level of evidence C). In this situation, the recommended 
pacing mode when there is no chronotropic incompetence is VDD/DDD (Class IIa; level 
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of evidence A). The option for the VVI mode in these cases is less consensual (class IIb; 
level of evidence C); where there is chronotropic incompetence DDDR mode (Class IIa; 
level of evidence A) or VVIR mode is recommended (class IIb; level of evidence C) 
(EPSTEIN et al., 2008). 
Rate-responsive pacing is associated with better exercise performance, improved daily 
activities, decrease of symptoms of shortness of breath, chest pain and palpitations and 
improved quality of life, compared with fixed-rate pacing. Therefore, rate-adaptive pacing 
is the pacing mode of first choice and fixed-rate VVI pacing should be abandoned in 
patients with AV block and also permanent AF. 
In second-degree type I AV block, the indication for permanent pacing is controversial, 
unless AV block causes symptoms or the conduction delay occurs at intra or infra His 
levels. The cause – effect relationship with symptoms is sometimes difficult to determine, 
especially when symptoms are non-specific and subtle. The progression to complete heart 
block is likely when there is a wide QRS complex (BRIGNOLE et al., 2013). 
PPM is recommended in patients with third or second-degree type II AV block irrespective 
of symptoms (Class I; level of Evidence C) (EPSTEIN et al., 2008). 
 
Furthermore, in patients with BBB or AV block and with reduced LVEF (<35%), RV 
pacing may worsen left ventricular dysfunction, and therefore biventricular pacing has been 
recommended. Another issue to consider is the place of conventional stimulation of the 
RV apex, which induces a pattern of LBBB and therefore leads to interventricular 
dyssynchrony. It has been proposed alternative RV pacing sites, such as pacing at the 
interventricular septum or at the right ventricular outflow tract (EPSTEIN et al., 2008). 
 
 
ATRIAL FIBRILLATION 
The onset of AF is influenced by several factors such as the presence of structural heart 
disease, hypertension, congestive heart failure, age, SSS, or pacing mode (ISRAEL, 2006). 
Several retrospective and randomized studies have demonstrated that pacing in the atrium 
reduces the incidence of atrial fibrillation compared to ventricular pacing in patients with 
AV block or SSS (ANDERSEN et al., 1997; CONNOLLY et al., 2000). However, this may occur 
because pacing in the right ventricular apex (RV) induces or sustains the atrial fibrillation, 
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while atrial pacing actually reduces the AF (SWEENEY et al., 2003). The potential 
antiarrhythmic mechanisms of atrial pacing are essentially due to reduction in the 
dispersion of atrial refractoriness associated with bradycardia and due to suppression of 
premature atrial contractions and pauses. 
In patients with indication for cardiac pacing with the purpose of preventing AF episodes, 
devices with specific algorithms for AF prevention must be implanted. 
 
 
There are other clinical entities associated with disturbances of rhythm and conduction 
where permanent pacing plays an important therapeutic role: 
- after acute phase of MI, permanent ventricular pacing is indicated for persistent and 
symptomatic third-degree AV block and second-degree AV block with or without 
alternating BBB (Class I; level of evidence C); 
- in hypersensitive carotid sinus syndrome, PPM is indicated for recurrent syncope 
caused by spontaneously occurring carotid sinus stimulation and carotid sinus 
pressure that induces ventricular asystole of more than 3 seconds. (Class I; Level of 
Evidence C); 
- after cardiac transplantation, PPM is indicated for persistent inappropriate or 
symptomatic bradycardia not expected to resolve (Class I; Level of Evidence C). In 
this situations, cardiac pacing has other goals as chronotropic support, AV synchrony 
and rejection monitoring;  
-  in patients with hypertrophic cardiomyopathy (HOCM), PPM is indicated in cases 
of symptomatic bradycardia induced by beta-blockers, when alternative therapies are 
not acceptable (Class IIa; level of evidence C); in cases of hypertrophic 
cardiomyopathy with resting or dynamic intracavitary gradient and drugs 
refractoriness (Class IIb; level of evidence C) (EPSTEIN et al., 2008). DDD pacing 
with a short AV interval in patients with HOCM contributes to decreased LV end-
systolic gradient. The pre-excitation of the right ventricular apex alters the pattern of 
the ventricular contraction creating a “dyssynchrony”. The changed activation 
pattern of the LV, along with the late activation of the basal part of the septum and 
reduced LV contractility, increases the LV systolic diameter and reduces the systolic 
anterior motion of the mitral valve. 
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3.2. IMPLANTABLE CARDIOVERTER DEFIBRILATOR 
Sudden cardiac death is the initial presentation for many patients with cardiac disease. Dr 
Michel Mirowski was a pioneering cardiologist who recognized the public health 
importance of this fact. His efforts led to the development of the implantable cardioverter 
defibrillator that has revolutionized the ability to prevent and treat sudden cardiac arrest. 
In 1968, Mirowski became the director of Sinai’s Hospital coronary care unit and was given 
protected time for research. Fortunately for his research, the hospital had a division of 
biomedical engineering and an animal laboratory, where he joined with Morton Mower, a 
junior cardiologist with extensive animal research experience, to begin work on an ICD. 
Only a month later they successfully tested their first crude prototype, made from a broken 
external defibrillator paddle, on a dog, however there was remained considerable 
antagonism in the cardiology community toward the concept of the ICD. 
In 1972, Mirowski was introduced to Stephen Heilman, a physician and engineer who had 
formed a small medical equipment company called Medrad. Heilman was excited by the 
concept of the ICD and immediately put the company’s engineers at Mirowski and 
Mower’s disposal. The partnership was fruitful and resulted in the production of the first 
ICD prototype small enough to be completely implanted in a dog in 1975. Mirowski and 
the group at Medrad further refined the prototype to make it suitable for human 
implantation and eventually received approval for such an implant from the FDA. After 
Mirowski and Mower enlisted the aid of colleagues at Johns Hopkins Hospital, cardiac 
surgeon Myron Weisfeldt and electrophysiologist Philip Reed, the first successful human 
implant of an ICD was performed in February 1980. Though the first ICD model was a 
success, it weighed 225 g, required a thoracotomy for implantation of the electrode 
patches, and was only capable of defibrillation.  
In the years that followed, numerous advances in ICD design have been made, including 
the development of the capacity of synchronized cardioversion for ventricular tachycardia 
and the development of a catheter-electrode-based implantable without a thoracotomy, in a 
similar manner to the standard pacemaker.  
Unlike the early prototypes, modern devices are much smaller, with the newest models 
weighing as little as 90 g and measuring less than a centimetre thick. In addition to having 
full pacemaker capabilities, all modern ICDs are capable of overdrive pacing 
(antitachycardia pacing), which can often terminate ventricular tachycardia without 
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resorting to shock therapy.  ICDs are also available with biventricular pacing (cardiac 
resynchronization therapy) to improve symptoms in selected patients with advanced heart 
failure (DEYELL et al., 2010). 
 
Based on the results of several randomized trials supporting the benefit of ICD, the 
indications for ICD implantation have been classified into two categories: primary 
prevention and secondary prevention. Primary prevention refers to the prevention of SCD 
in individuals without a history of cardiac arrest or sustained VT. Secondary prevention 
refers to the prevention of SCD in those patients who have survived a prior cardiac arrest 
or sustained VT (EPSTEIN et al., 2008). 
 
According to NICE - National Institute for Health and Care Excellence (ADES et al., 2007), 
which provides national guidance and advice to improve health and social care in England, 
ICDs are recommended: 
As primary prevention, for patients who have: 
.: a history of previous (more than 4 weeks) myocardial infarction and: 
either 
- left ventricular dysfunction with an LVEF of less than 35% (no worse than 
class III of the NYHA functional classification of heart failure), and 
- non-sustained VT on Holter, and 
- inducible VT on a EP study 
or 
- left ventricular dysfunction with an LVEF of less than 30% (no worse than 
class III of the NYHA functional classification of heart failure) and 
- QRS duration of equal to or more than 120 milliseconds 
.: have a familiar cardiac condition with a high risk of sudden death, such as long QT 
syndrome, hypertrophic cardiomyopathy, Brugada syndrome or Arrhythmogenic 
Right Ventricular Dysplasia, or have undergone surgical repair of congenital heart 
disease. 
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As secondary prevention, in patients that: 
- have survived a cardiac arrest caused by either ventricular tachycardia or ventricular 
fibrillation; 
- have spontaneous sustained VT causing syncope or significant haemodynamic 
compromise; 
- have sustained VT without syncope or cardiac arrest, and also have an associated 
reduction in LVEF of 35% or less but their symptoms are no worse than class III of 
the New York Heart Association (NYHA) functional classification of heart failure. 
 
For the specific group of patients with CHF, and that exhibit criteria for CRT, i.e. LVEF ≤ 
35% and QRS prolongation ≥ 120 ms, is recommended devices for cardiac 
resynchronization with defibrillation function (CRT-D) to reduce mortality and morbidity 
in patients with class III/IV of NYHA that are symptomatic, despite optimal medical 
therapy received, and with an expected survival ≥ 1 year (DICKSTEIN et al., 2010). 
The cardiac conditions with a high risk of sudden cardiac death mentioned before, such as 
LQTS, HCM, Brugada syndrome or ARVD are rare and, therefore, there are no large 
randomized studies that prove the actual effectiveness of these ICDs. However, the results 
of some small retrospective studies have lead the majority of the experts to believe that this 
measure is actually effective to reduce the mortality in individuals with these conditions 
(recommendation of class IIa; level of evidence C) (EPSTEIN et al., 2008). 
On the other hand, patients with VT or VF due to reversible causes should not receive an 
ICD. This includes patients with VT or VF within the first 48 hours of an acute MI due to 
electrolyte abnormalities or due to the effects of drug use or intoxication. Patients with 
incessant VT or VF are also not candidates for an ICD until their arrhythmia is brought 
under control with antiarrhythmic or ablation therapies.  
Severe psychiatric conditions are also relative contraindications for an ICD, especially if 
follow-up will be dificult or if ICD discharges would exacerbate the psychiatric condition.  
Patients with severe symptomatic heart failure (NYHA class IV) or with frequent 
hospitalizations are more likely to die from cardiac pump failure than VT or VF and should 
not have an ICD implanted unless their clinical status improves. Similarly, patients whose 
life expectancy is less than 1 year due to cardiac or non-cardiac disease are not likely to 
survive to benefit from an ICD. 
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3.3. CARDIAC RESYNCHRONIZATION THERAPY 
The first papers regarding the short-term hemodynamic effects of LV pacing versus 
simultaneous stimulation of the LV and RV were published in the decade of the 70s. The 
application of techniques known as CRT began in 1994 when Cazeau et al. described the 
first cases of atrioventricular pacemakers implanted in patients with CHF and no indication 
for cardiac pacing (CAZEAU et al., 1994). 
Cardiac dyssynchrony is complex and multifaceted. Prolongation of the AV interval delays 
systolic contraction, which might then encroach on early diastolic filling. Atrial pressure 
falls as the atria relax. If ventricular contraction is delayed, then LV diastolic pressures will 
exceed atrial pressure causing diastolic mitral regurgitation. The loss of ventricular pre-load 
then leads to a reduction in LV contractility, due to loss of the Starling mechanism. Both 
inter and intra-ventricular conduction delays lead to asynchronous contraction of LV wall 
regions (ventricular dyssynchrony), impairing cardiac efficiency and reducing stroke volume 
and systolic blood pressure. Poorly coordinated papillary muscle function may cause or 
aggravate functional systolic mitral regurgitation. Impaired performance promotes adverse 
LV remodelling. 
Cardiac resynchronization therapy helps to restore AV, inter and intra-ventricular 
synchrony, improving LV function, reducing functional mitral regurgitation and inducing 
LV reverse remodelling, as evidenced by increases in LV filling time and LVEF, and 
decreases in LV end-diastolic and end-systolic volumes, mitral regurgitation and septal 
dyskinesia. The dominant mechanism of benefit is likely to vary from one patient to the 
next and within an individual patient over time. It is possible that no single measure will 
accurately predict the response to CRT, since the mechanism of benefit is so 
heterogeneous. 
The CRT also carries an antiarrhythmic effect and its benefits may occur through multiple 
mechanisms. The first pathophysiological mechanism is related to the myocardial reverse 
remodelling observed in CRT. The myocardial fibre shortening can lead to a reduction of 
triggered activity or to possible modifications of re-entrant circuits. The hemodynamic 
improvement and consequent decrease in sympathetic tone is another mechanism 
contributing for the antiarrhythmic effect. Increased sympathetic tone is associated with a 
higher substrate for arrhythmias through multiple mechanisms (triggered activity, 
shortening of refractory periods, etc.). Finally, the stimulation of both ventricles in 
simultaneous can be associated with electrophysiological effects which lead to a lower 
MASTER’S DEGREE IN CARDIAC PHYSIOLOGY | INTERNSHIP IN ARRHYTHMOLOGY 
47    
  Final  Report     
percentage of arrhythmias. The preventive effect of electrophysiological inducibility is 
probably related to a lower dispersion of refractoriness, once during simultaneously 
biventricular stimulation, depolarization and repolarization phases occur within a short 
interval of time, reducing the reentry gap of the stimulus through zones of slow conduction 
(MONT, 2005). 
Currently, the main goal of the CHF treatment, in addition to relieving symptoms, 
preventing major morbidity and reducing mortality, attempts to prevent significantly the 
progression of the disease, especially the transition from asymptomatic LV dysfunction to 
significant CHF. Although CRT is mainly indicated to restore the ventricular synchrony, 
not every patient with CHF exhibits ventricular dyssynchrony, and therefore, it is 
important an accurate selection of patients undergoing CRT (KENNY, 2007). 
 
PATIENTS IN SINUS RHYTHM 
There is conclusive evidence of both short and 
long-term benefits of CRT in patients with NYHA 
class III from a series of randomized and controlled 
trials. MIRACLE (ABRAHAM et al., 2002), 
COMPANION (BRISTOW et al., 2004) and CARE-
HF (CLELAND et al., 2005) demonstrated the 
9<E<[KJ F= -/ in the quality of life, in the New 
York Heart Association functional class, in the 
exercise capacity and, on the other hand, in the 
reduction of hospital admissions secondary to CHF.  
 
Indication of Class I (BRIGNOLE et al., 2013): 
1) CRT-P/CRT-D is recommended in 
chronic HF patients, on sinus rhythm with 
LBBB with QRS duration > 150 ms and 
LVEF ≤ 35%, who remain in NYHA 
functional class II, III and ambulatory IV 
despite having received optimal medical 
therapy (Level of evidence A). 
Recommendations Class a Level b
1) LBBB with QRS 
duration >150 ms. 
CRT is recommended in 
chronic HF patients and LVEF 
≤35% who remain in NYHA 
functional class II, III and 
ambulatory IV despite adequate 
medical treatment. d
I A
2) LBBB with QRS 
duration 120–150 ms.
CRT is recommended in 
chronic HF patients and LVEF 
≤35% who remain in NYHA 
functional class II, III and 
ambulatory IV despite adequate 
medical treatment. d
I B
3) Non-LBBB with QRS 
duration >150 ms. 
CRT should be considered in 
chronic HF patients and LVEF 
≤35% who remain in NYHA 
functional class II, III and 
ambulatory IV despite adequate 
medical treatment. d
IIa B
4) Non-LBBB with QRS 
duration 120–150 ms.
CRT may be considered in 
chronic HF patients and LVEF 
≤35% who remain in NYHA 
functional class II, III and 
ambulatory IV despite adequate 
medical treatment. d
IIb B
5) CRT in patients with 
chronic HF with QRS duration 
<120 ms is not recommended.
III B  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Indications for cardiac 
resynchronization therapy in patients in 
sinus rhythm. 
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PATIENTS IN ATRIAL FIBRILLATION 
AF is the most common arrhythmia in patients with HF. The EuroHeart Failure survey 
reported that up to 45% of patients with HF also presented with intermittent or permanent 
AF. The overall prevalence of new-onset AF in patients hospitalized for congestive heart 
failure was 13%, ranging from 8% to 36% in different European regions. In chronic HF, 
the prevalence of AF is linked directly to disease severity, ranging from 10% to 20% in 
mild to moderate CHF up to 50% in patients with advanced disease. Incident AF is 
associated with a worse prognosis but it is unclear whether patients with chronic AF have a 
worse prognosis than those in sinus rhythm, after 
correcting for age and co-morbidity. AF may simply 
be a marker of more severe disease.  
There are two ways of considering CRT for AF 
patients: (a) AF patients with moderate to severe 
HF and a haemodynamic indication for CRT and 
(b) patients with a fast ventricular rate with HF or 
LV dysfunction justifying a strong rate control 
strategy with an AV junction ablation.  The table 4 
shows the recommendations develop by the 
European Society of Cardiology (ESC) in 
association with the European Heart Rhythm 
Association (EHRA) for cardiac resynchronization 
therapy in this group of patients (BRIGNOLE et al., 
2013). 
 
 
PATIENTS WITH HEART FAILURE AND CONVENTIONAL PACEMAKER INDICATIONS 
Previous studies have clearly shown that RV apical pacing might have deleterious effects 
on cardiac structure and function. Moreover, different clinical trials have shown that there 
was a positive correlation between the percentage of RV pacing and the occurrence of 
adverse events. Therefore, additional benefit of biventricular pacing should be considered 
in patients requiring permanent or frequent RV pacing for bradycardia, who have 
symptomatic HF and low LVEF. In fact, results from small randomized trials are 
encouraging, demonstrating clinical subjective improvement, less hospitalization and 
Recommendations Class a Level b
1) Patients with HF, wide 
QRS and reduced LVEF:
1A)  CRT should be 
considered in chronic HF 
patients, intrinsic QRS ≥120 
ms and LVEF ≤35% who 
remain in NYHA functional 
class III and ambulatory IV 
despite adequate medical 
treatmentd, provided that a 
BiV pacing as close to 100% 
as possible can be achieved.
IIa B  
1B) AV junction ablation 
should be added in case of 
incomplete BiV pacing.
IIa B
  
 
2) Patients with 
uncontrolled heart rate 
who are candidates for 
AV junction ablation. 
CRT should be considered in 
patients with reduced LVEF 
who are candidates for AV 
junction ablation for rate 
control.
IIa B
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Indications for cardiac 
resynchronization therapy in patients 
with permanent atrial fibrillation. 
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improved cardiac function on the CRT study phase compared with the RV study phase. 
The above results are consistent with those found in other observational studies in which 
patients underwent CRT upgrade because of worsening of severe symptoms of HF and 
deterioration of cardiac function several months or years after RV pacing for bradycardia. 
Finally, five studies compared the clinical outcomes 
of patients who received an upgrade to CRT with 
those who received a de novo CRT implant for 
conventional indications. During the subsequent 
follow-up of 3 to 38 months, upgraded patients 
showed similar improvement to the de novo patients. 
In particular, the European CRT Survey showed 
that there were no significant differences in clinical 
outcomes, mortality or complication rates between 
upgrades and de novo procedures. Furthermore, it is 
important to highlight that upgrade to CRT is 
associated with a high complication rate, which was 
18.7% in a recent large prospective trial. The 
decision to upgrade should therefore be made after 
careful assessment of the risk–benefit ratio.  
Despite the lack of large randomized trials, there is sufficient evidence and general 
consensus that, in patients paced for conventional bradycardia who, during follow-up, 
develop severe symptoms of HF and have depressed EF, an upgrade to CRT pacing is 
likely to reduce hospitalization and improve their symptoms and cardiac performance 
(BRIGNOLE et al., 2013). 
 
 
3.4. RADIOFREQUENCY ABLATION 
Catheter ablation, especially with radiofrequency energy (RF), was the more significant 
progress and with greater impact in cardiology in the recent years. Radiofrequency ablation 
has become the standard method for the management of many types of cardiac 
arrhythmias. Its safety and efficacy have been well described and the final outcome of RF-
Table 5. Indications for upgraded or de 
novo cardiac resynchronization therapy 
in patients with conventional 
pacemaker indications and heart failure. 
Recommendations Class a Level b
1) Upgrade from 
conventional PM or ICD. 
CRT is indicated in HF patients 
with LVEF <35% and high 
percentage of ventricular 
pacing who remain in NYHA 
class III and ambulatory IV 
despite adequate medical 
treatment. d
I B
 
 
2) De novo cardiac 
resynchronization 
therapy.
CRT should be considered in
HF patients, reduced EF and 
expected high percentage of 
ventricular pacing in order 
to decrease the risk of 
worsening HF. 
IIa B  
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based ablation is frequently so satisfying that many patients would prefer it over medical 
therapy. Radiofrequency ablation takes advantage of physical properties of resistive heating. 
Electrical voltage produced by the RF generator is impressed upon the tissue and causes 
electrical force emanating from the tip of an intracardiac catheter electrode positioned 
against the cardiac tissue, which is transformed into heat by resistive mechanism. This local 
heating is then dispersed to surrounding tissue by conductive mechanism. As such, deeper 
tissue is heated to a lesser degree than the endocardial surface. This heating of heart muscle 
cause irreversible damage and thereby prevent heart racing. 
Since its introduction into the clinic in 1982 with the ablation of anomalous atrioventricular 
pathways, this was later followed and demonstrated by the effectiveness in the curative 
treatment of conditions such as ablation of accessory pathways associated with pre-
excitation syndromes and in supraventricular tachyarrhythmias, particularly nodal reentrant 
tachycardias. Subsequently, and in the current decade, the ablation therapy has been used in 
the treatment of atrial tachycardias, atrial Flutters, Atrial Fibrillation and ventricular 
tachycardias (O'ROURKE et al., 2002). 
 
 
RF ABLATION FOR ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA 
The AV node includes "fast" pathways with atrial connections located anteriorly and 
"slow" pathways with atrial connections located posteriorly. In the most common type of 
AVNRT, the slow pathway is used for anterograde conduction and the fast pathway is used 
for retrograde conduction. Both pathways are needed to maintain AVNRT. The atrial 
connection of either the fast or slow pathway can be ablated, thereby eliminating AVNRT. 
Slow pathway ablation is preferred because of a lower incidence of producing AV block, a 
greater likelihood of maintaining a normal PR interval during sinus rhythm, and its efficacy 
in the atypical forms of AVNRT. 
 
Recommendation of Class I (ZIPES et al., 1995): 
1) Patients with symptomatic sustained AVNRT that is drug resistant or the patient 
is drug intolerant or does not desire long-term drug therapy. 
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RF ABLATION OF ATRIAL TACHYCARDIA, FLUTTER AND FIBRILLATION 
The use of ablation for symptomatic AF has increased over the past 10 years in the UK. In 
2010, approximately 5000 ablation procedures for AF were performed. There is a good 
understanding that treating AF with ablation early within its clinical course gives better 
results than after it has been present for many years. In addition, there is evidence that in 
individuals who have advanced heart disease, ablation results are less successful. 
AF has historically been classified into 3 groups: paroxysmal - where AF starts and stops of 
its own accord; persistent where AF requires medical intervention, in the form of electrical 
cardioversion, to restore normal sinus rhythm; and permanent – where AF is accepted in 
the long-term. 
The initial studies of AF ablation were performed mainly on younger patients with 
paroxysmal AF and structurally normal hearts. In general this represents a group of 
patients early in the clinical course of their AF illness. A cost-effectiveness analysis of these 
studies has shown that ablation is cost-effective in comparison to medical therapy in this 
group of patients. 
Ablation is now also increasingly used in patients with persistent AF. Some of these 
patients have this pattern of AF early within their clinical course and have been shown in 
observational studies to have similarly good results to patients with paroxysmal AF. It is 
important for the clinician when selecting patients with persistent AF for ablation to be 
mindful of the clinical aspects that predict the best chances of a successful result. In 
general, however, patients with persistent AF more often require repeat procedures to 
achieve a successful result and longer-term follow-up data is not yet available (COWAN et al., 
2014). There are increasing numbers of publications related to ablation of atrial 
tachycardias, including tachycardia in the region of the sinus node and ablation of 
inappropriate sinus tachycardia. Radiofrequency ablation has also been effective in 
eliminating counterclockwise atrial flutter.  
 
Recommendations of Class I (ZIPES et al., 1995): 
1) Patients with atrial tachycardia that is drug resistant or the patient is drug 
intolerant or does not desire long-term drug therapy; 
2) Patients with atrial flutter that is drug resistant or the patient is drug intolerant or 
does not desire long-term drug therapy. 
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Recommendations of Class II (ZIPES et al., 1995): 
1) Atrial flutter/atrial tachycardia associated with paroxysmal AF when the 
tachycardia is drug resistant or the patient is drug intolerant or does not desire long-
term drug therapy; 
2) Patients with AF and evidence of a localized site(s) of origin when the tachycardia 
is drug resistant or the patient is drug intolerant or does not desire long-term drug 
therapy. 
 
 
RF ABLATION OF ACCESSORY PATHWAYS 
The safety, efficacy and cost-effectiveness of radiofrequency ablation of an accessory AV 
pathway has made ablation the treatment of choice in most patients who have AV 
reentrant tachycardia or atrial fibrillation (or other atrial tachyarrhythmias) associated with a 
rapid ventricular response via the accessory pathway. This procedure also carries some 
complications as possibility of valve damage, pericardial tamponade, AV block, and 
pulmonary or systemic emboli, although rare late deaths have been reported. 
 
Recommendations of Class I (ZIPES et al., 1995): 
 1) Patients with symptomatic AV reentrant tachycardia that is drug resistant or the 
patient is drug intolerant or does not desire long-term drug therapy; 
2) Patients with atrial fibrillation (or other atrial tachyarrhythmia) and a rapid 
ventricular response via the accessory pathway when the tachycardia is drug resistant 
or the patient is drug intolerant or does not desire long-term drug therapy; 
 
 
RF ABLATION OF VENTRICULAR TACHYCARDIA 
Radiofrequency ablation of VT has been used with varying degrees of success in patients 
with ischemic disease, cardiomyopathy, bundle branch reentry, and various forms of 
idiopathic VT. Mapping and ablation techniques differ, depending on the type of VT. In 
patients without structural heart disease, only a single VT is usually present, and catheter 
MASTER’S DEGREE IN CARDIAC PHYSIOLOGY | INTERNSHIP IN ARRHYTHMOLOGY 
53    
  Final  Report     
ablation is curative. In patients with extensive structural heart disease, especially those with 
prior MI, multiple VTs are often present. Catheter ablation of a single VT in such patients 
may be only palliative and may not eliminate the need for other antiarrhythmic therapy. 
 
Recommendations of Class I (ZIPES et al., 1995): 
 1) Patients with symptomatic sustained monomorphic VT when the tachycardia is 
drug resistant or the patient is drug intolerant or does not desire long-term drug 
therapy; 
2) Patients with bundle branch reentrant ventricular tachycardia; 
3) Patients with sustained monomorphic VT and an ICD who are receiving multiple 
shocks not manageable by reprogramming or concomitant drug therapy. 
 
 
Although RF ablation has been widely used on a daily practice, this technique has some 
limitations. The success of reaching deeper tissue is not only dependent on those basic 
physical properties of RF energy. Other variables, such as electrode-to-tissue contact and 
tissue geometry and pathology also play a big role. 
The dependence of effective RF ablation upon good contact also limits the utility of this 
method for the creation of linear ablation. With RF technology, linear ablation using 
stationary catheter would require delivery of RF energy over multiple electrodes 
simultaneously. Thus, to create linear lesion, the point-and-drag method is still frequently 
used. Several new methods are being employed to overcome uneven RF delivery with the 
multipolar catheter technique. Another limitation to the use of conventional RF technology 
for the creation of linear lesion lies in its limited depth. While a 3-5 mm ablation depth may 
be sufficient in some instances, it would be unlikely to produce uniform transmural lesion 
in some areas of the heart with widely variable thickness, such as the trabeculated portion 
of the right atrium. An appreciation of the biophysics and pathophysiology of RF energy 
heating of myocardium during catheter ablation will help the operator to make the proper 
adjustment to optimize ablation safety and success. A tissue temperature of 50ºC needs to 
be reached to achieve irreversible tissue injury. This likely occurs as a result of sarcolemma 
membrane injury and intracellular calcium overload. The 50ºC isotherm determines the 
boundary of the lesion. Greater lesion size is achieved with high power delivery and higher 
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intramural tissue temperatures. Monitoring surface temperature is useful to help prevent 
boiling of blood with coagulum formation and a sudden increase in electrical impedance.  
Although this limitation, recent progress with cooling and irrigation of the electrode has 
improved RF ablation ability in producing deeper lesions (LIEM & DOWNAR , 2001). 
In summary, RF catheter ablation remains the dominant modality for ablative therapy of 
arrhythmias. This technology is simple, has a high success rate, and has a low complication 
rate. Alternative sources of energy are being tested. Cryoablation and ablation using laser 
and microwave energy have being tested and promoted as being easier, safer, or more 
efficacious but clinical data are still limited.  Despite the fact, they are unlikely to supplant 
RF energy as the first choice for ablation of most arrhythmias (HUANG & WOOD, 2010). 
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Chapter II 
INTERNSHIP ACTIVITY 
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1. CONCEPTUALIZATION 
 
The internship was performed under the second year of the Master’s Degree in Cardiac 
Physiology – specialization in Arrhythmology, in order to understand and participate in the 
daily dynamics of a Cardiac Department, addressing both the diagnosis and the treatment 
of arrhythmias. 
The main goal of the internship was to apply scientific and technical knowledge acquired 
during the course in the daily practice and in the clinical context, whether in the field of 
non-invasive electrocardiography as well as in invasive Pacing and Electrophysiology areas. 
Thus, the practice was composed of several modules having the highest workload focused 
on the Pacing and Electrophysiology areas.  
The completion of this Master’s degree allowed me to (re)acquire and develop varied 
expertise in Arrhythmology, from basic concepts and principles of electrocardiography to 
electrophysiological interpretation of complex arrhythmias, as well as its implications in the 
daily clinical practice. 
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2. METHODOLOGY 
2.1. INTERNSHIP ORGANIZATION 
The internship was comprised of 400 hours allocated as follows: 130 hours of Pacing; 130 
hours of Electrophysiology; 110 hours of non-invasive Electrocardiography and 30 hours 
of Cardiac Imaging. 
These modules were divided between two hospitals of the National Health Service 
Foundation Trust in the United Kingdom. The non-invasive electrocardiography module 
(Holter and Exercise Tolerance Test) was performed at the Luton and Dunstable Hospital, 
integrated in my professional activity, and supervised by Roderick Macintosh, Principal 
Cardiac Physiologist. On the other hand, the invasive modules of Pacing and 
Electrophysiology were performed at the Harefield Hospital, part of the Royal Brompton 
& Harefield Hospital NHS Foundation Trust - one of the largest and most experienced 
centres in the world for heart and lung transplants, with an worldwide reputation for heart 
and lung research, and supervised by Robert Edwards, Senior Chief Cardiac Physiologist. 
Among the various existing labs for the diagnosis and/or treatment of heart disease at 
Harefield Hospital, there is lab dedicated to electrophysiology studies exclusively. The lab is 
fully equipped for the performance of electrophysiology studies and radiofrequency 
ablation in cases where this is indicated. In the centre of the room there is a tilting table; at 
the bedside of the patient a C-arm X-ray equipment; in the opposite side to the operator all 
the additional equipment that allows monitoring and tracking of the whole procedure, as 
the fluoroscopy monitors, the polygraph monitors, the ECG monitor, a defibrillator and 
the RF delivery equipment. The two anatomical mapping systems, Carto 3 and NavX, are 
also located in this area. Both disinfection area and the storage room for the material 
required during the procedures, and also a cleaning zone and deposit of sterile materials are 
"inside" the room itself, allowing easy, fast and constant access by the multiple members of 
the team. 
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The Cardiac department also has an area devoted to non-invasive cardiology with plenty of 
rooms intended for clinical use, two of which are exclusively used for the Pacing clinic. The 
time allocated for the interrogation of each patient's device is about 20 to 30 minutes. 
Regarding the clinical practice at Harefield Hospital, it was necessary to sort some 
bureaucratic issues which encompass a formal request and consequent authorization: firstly 
to my superiors Jenny Cadman (Deputy for Cardiology Department) and Roderick 
Macintosh (Senior Chief Cardiac Physiologist); posteriorly, to Julie Rochelle and Robert 
Edwards, Principal Cardiac Physiologist and Senior Chief Cardiac Physiologist for EP 
Laboratory respectively. To complete the authorization process, the request was submitted 
to the Board of Directors at the Royal Brompton & Harefield Hospital. 
As it would not be possible my absence from my professional activity for a consecutive 
period of time in order to complete the internship, a special request was drawn up in order 
to gain permission to perform my weekly work time in only 4 days (instead of the ordinary 
5 days), in order to obtain one day available per week to fulfil the total number of hours 
required in the academic calendar. 
 
 
2.2. SCHEDULE 
The second year of the Master was compound by four simultaneous activities: a revision of 
the literature; the clinical practice in non-invasive electrocardiography; the clinical practice 
in Pacing and Electrophysiology; the elaboration of a final internship report. 
During the internship, it was necessary to make three requests for postponement of six 
months in order to complete the hours concerted in the academic calendar and its final 
report. 
The organization of the second year of the Master’s degree is outlined in following table: 
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Table 6. Schedule of the internship. 
 
2.3. DATA COLLECTION METHODOLOGY 
The revision of the literature was performed via scientific research in online platforms such 
as Cardiosource, PubMed and NHS Athens, where papers from various newspapers and 
journals in the areas of interest were identified, as well as via the consultation of some 
textbooks. 
The clinical information regarding the procedures observed/performed was also obtained 
by consulting the patient’s medical records placed in the hospital’s database. 
It is important to mention that all the ethical provisions regarding patient confidentiality 
and anonymisation were met throughout the internship. 
 
2.4. STATISTICS 
The data collected during the clinical practice was entered and organized in a database, 
being statistically analyzed with the SPSS 17.0 statistical software. 
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3. RESULTS 
 
The results presented in this chapter focus essentially on the two main areas that 
constituted this internship: the pacing clinic and electrophysiology studies, mostly realized 
at Harefield Hospital NHS Foundation Trust. 
Let us begin by describing the Electrophysiology module, a period where we watched and 
collaborated on several studies, in which multiple data relating to the respective procedures 
were collected, allowing the preparation of this report. 
We performed 41 EP studies, almost equally distributed between the genders, with a slight 
predominance of the female gender. 
	   Age	  (years)	  
	   N	   N	  (%)	   Mean	  
Standard	  
Deviation	  
Minimum	   Maximum	  
Gender	  
Female	   22	   53,7	   48,545	   19,942	   18,00	   86,00	  
Male	   19	   46,3	   62,474	   12,144	   40,00	   80,00	  
Total	   41	   100	   55,000	   18,017	   18,00	   86,00	  
Table 7. Demographic characterization according to age and gender. 
By the analysis of the table 7 we also verified that the mean age of subjects was 55 +/- 
18.017 years and that the males underwent the procedure at an older age. 
 
Chart 1. Distribution by type of procedure. 
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Regarding the type of procedure, we can verify through the chart 1 outlined above that the 
ablation therapy was attempted in most of the studies (90,2%); only in four cases this 
therapeutic approach was not performed. These studies where ablation was not applied 
were carried out in subjects whose symptoms were palpitations and with the following 
indications of documented VT, Atrial tachycardia and palpitations (2 subjects). In all of 
them, it was not possible to induce tachycardia and thus given as completed study with no 
therapeutic attempt. Note that all subjects had sinus rhythm on the baseline ECG at the 
entry to the laboratory. 
 
 
Chart 2. Indication for EP study. 
Considering the indication for EP study, we can verify that the major indication found 
study was SVT, followed by Atrial Fibrillation. Among the patients referred due to SVT, 13 
were diagnosed with AVNRT, 3 with focal atrial tachycardia, 1 with AVRT (with concealed 
accessory pathway) and there was a patient where it was not possible to induce any 
arrhythmia. Regarding the patients referred with Atrial Flutter, the EP study showed that 3 
patients had typical counterclockwise flutter while one patient had atypical clockwise CTI 
flutter. 
 
By the analysis of the chart 3, we conclude that the symptom mostly present in individuals 
who underwent EP study and/or ablation was palpitations, in 78% of cases (n = 32), 
followed by dyspnoea (n = 7) and dizzy spells (n = 2). There were no cases of 
asymptomatic subjects prior to the procedure. 
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Chart 3. Symptomatology prior to the procedure. 
 
Having said that, we looked for a possible association between symptomatology and the 
presence (or absence) of cardiac pathology. Thus, through the analysis of the table 8, we 
verified that all subjects who presented with symptoms of dyspnoea or dizzy spells have a 
history of cardiac disease, such as Heart Failure, Coronary Artery Disease, valvular heart 
disease or Cardiomyopathy. In contrast, in the group who had symptoms of palpitations 
the majority (71.9%) have a background without any known cardiac disease. 
 	  
	   Comorbidity	  
	  
Apparently	  
normal	  
heart	  
Cardiomyo
pathy	  
Congenital	  
Structural	  
Defect	  
Coronary	  
Artery	  
disease	  
Heart	  
Failure	  
HTN	  
Valvular	  
Heart	  
disease	  
Total	  
Dizzy	  spells	  
N	   0	   0	   0	   0	   0	   2	   0	   2	  
%	  in	  group	   0,0%	   0,0%	   0,0%	   0,0%	   0,0%	   100,0%	   0,0%	   100,0%	  
%	  total	   0,0%	   0,0%	   0,0%	   0,0%	   0,0%	   4,9%	   0,0%	   4,9%	  
Dyspnoea	  
N	   0	   3	   0	   0	   3	   0	   1	   7	  
%	  in	  group	   0,0%	   42,9%	   0,0%	   0,0%	   42,9%	   0,0%	   14,3%	   100,0%	  
%	  total	   0,0%	   7,3%	   0,0%	   0,0%	   7,3%	   0,0%	   2,4%	   17,0%	  
Palpitations	  
N	   23	   1	   1	   2	   1	   2	   2	   32	  
%	  in	  group	   71,9%	   3,1%	   3,1%	   6,3%	   3,1%	   6,3%	   6,3%	   100,0%	  
%	  total	   56,1%	   2,4%	   2,4%	   4,9%	   2,4%	   4,9%	   4,9%	   78,1%	  
Total	  
N	   23	   4	   1	   2	   4	   4	   2	   41	  
%	  total	   56,1%	   9,8%	   2,4%	   4,9%	   9,8%	   9,8%	   4,9%	   100,0%	  
Table 8. Comorbidity characterization and its distribution according to symptomatology. 
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The most frequent arrhythmias found as a diagnostic of the EP study were the AVNRT (n 
= 13) and atrial fibrillation (n= 11), as we can visualize on the chart 4. 
 
Chart 4. Diagnostic of the EP study. 
Amongst the 11 subjects where the presence or induction of atrial fibrillation was 
confirmed during the EP study, 5 subjects had persistent AF, already present in the 
baseline ECG prior to the procedure, and 6 subjects had paroxysmal AF with sinus rhythm 
in the baseline ECG prior to the procedure. 
 
 
Chart 5. Prevalence and distribution of supraventricular arrhythmias according to the mechanism. 
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In the chart 5, we can verify the distribution of the different tachyarrhythmias characterized 
by a reentrant mechanism. 12 cases of typical slow-fast type of AVNRT and 1 case of 
atypical fast-slow type were observed. Furthermore, it was successfully performed ablation 
of a mid-septal accessory pathway in two cases: a 37 years female patient with pre-
excitation pattern in the baseline ECG (overt accessory pathway); a 40 years male patient 
with history of palpitations, sinus rhythm on baseline ECG and possible episode of SVT 
(concealed accessory pathway). Regarding the atrial flutter, it was observed a successful 
ablation in 3 subjects with typical counterclockwise flutter and in 1 subject with atypical 
clockwise flutter.  
 
We now present results from a more technical point of view. Regarding the use of new 
non-fluoroscopic mapping techniques that we address with some detail in the chapter I of 
this report, we can conclude straight away that these resources are used on a daily basis, 
being almost certain its utilization in cases of Atrial fibrillation, Atrial flutter and ventricular 
ectopy/tachycardia, whose aim is to find the focus of origin of the arrhythmia.  
 
Chart 6. Characterization of the sample according to mapping technique used. 
The conventional electrodes mapping technique was used in 22 cases (53,7%) and one of 
two electroanatomical mapping techniques in 19 cases (46,3%). 
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   Mapping	  Technique	  
	   Carto	   NavX	  
Conventional	  
electrodes	  
Total	  
Atrial	  Fibrillation	  
N	   5	   4	   2	   11	  
%	  in	  group	   45,5%	   36,4%	   18,2%	   100,0%	  
AVNRT	  
N	   0	   0	   13	   13	  
%	  in	  group	   0,0%	   0,0%	   100,0%	   100,0%	  
AVRT	  
N	   0	   0	   2	   2	  
%	  in	  group	   0,0%	   0,0%	   100,0%	   100,0%	  
Flutter	  
N	   3	   1	   0	   4	  
%	  in	  group	   75,0%	   25,0%	   0,0%	   100,0%	  
Atrial	  Tachycardia	  
N	   0	   1	   2	   3	  
%	  in	  group	   0,0%	   33,3%	   66,7%	   100,0%	  
No	  arrhythmia	  
induction	  
N	   0	   0	   1	   1	  
%	  in	  group	   0,0%	   0,0%	   100,0%	   100,0%	  
VT/ectopics	  
N	   5	   0	   2	   7	  
%	  in	  group	   71,4%	   0,0%	   28,6%	   100,0%	  
Total	  
N	   13	   6	   22	   41	  
%	  total	   31,7%	   14,6%	   53,7%	   100,0%	  
Table 9. Characterization of the mapping technique used according to the study diagnostic. 
As mentioned above and by the analysis of the table 9, we verify that 3D mapping 
technique (Carto or NavX) was used in most cases of atrial fibrillation and ventricular 
ectopy/tachycardia (81,8% and 71,4% of these, respectively) and in all cases of Flutter (n = 
4). In contrast, the conventional electrodes system was used in all cases of reentrant 
tachyarrhythmias, AVNRT (n = 13) and AVRT (n = 2). 
Successful ablation was considered in cases with confirmation of no induction of 
arrhythmia after ablation; on the other hand, partial success was considered in cases where 
it was not possible to confirm the total suppression of the arrhythmia circuit or ventricular 
ectopy. 
 
Chart 7. Outcome of the electrophysiology studies. 
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We can observe from the chart 7 that over 80% of the studies have been completed 
successfully, i.e. the outcome was the successful ablation of the arrhythmia. However, in 3 
of the procedures where ablation therapy was applied, it was not possible to fully eliminate 
the arrhythmia. Two of these cases refer to patients with persistent atrial fibrillation: 
- the first, technically successful pulmonary veins (PV), LA “roof”, Mitral valve isthmus 
(MVI), complex fractionated electrogram (CFE) and cavotricuspid isthmus (CTI) ablation, 
although not fully proven block at the end; 
- the second, successful isolation of 3 of 4 PVs with residual connection to the lower right 
PV (bi-directional) and roof line with unproven block. 
The third case refers to a patient with background of Cardiomyopathy, presenting with 
dyspnoea and frequent symptomatic ventricular ectopy, with origin in the right ventricular 
outflow tract. In this case, there was incomplete suppression of the ectopy. 
 
The real incidence of complications in electrophysiology studies (especially catheter 
ablation) varies according to the experience of the professionals. Today, with enhanced 
access to new technology and expertise that provides additional safety to radiofrequency 
ablation, complications during and after the procedure has become minimized. Still, these 
happen and the most frequent is the pericardial effusion with possible cardiac tamponade. 
 
Chart 8. Complications during and after the EP study. 
There was only a minor complication in the 41 studies observed: a first degree AV block in 
an individual with successful slow pathway ablation for AVNRT, where the conventional 
electrodes system was used as mapping technique. This is a minor complication still 
somewhat frequent in this type of procedure. 
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The performance of a TOE prior to the procedure is recommended for the 
treatment/ablation of atrial tachyarrhythmias, in order to exclude the presence of atrial 
thrombus. Its formation is favoured and potentiated by the substrate of the arrhythmia; 
and the embolic risk is also boosted by reversing these arrhythmias back to sinus rhythm 
(principal aim of the ablation in these cases). 
The transseptal approach is performed when there is a need to access the left atrium. This 
happens in cases of pulmonary veins isolation for the treatment of atrial fibrillation, atrial 
tachycardias where the arrhythmia circuit extends to this cavity, and AVRT where the 
accessory pathway is only achievable through the left atrium. 
	   Approaches	  
	   TOE	   GA	   Transseptal	  punction	   	  
	   Yes	   No	   Yes	   No	   Yes	   No	   Total	  
Atrial	  
Fibrillation	  
N	   9	   2	   9	   2	   9	   2	   11	  
%	  in	  group	   81,8%	   18,2%	   81,8%	   18,2%	   81,8%	   18,2%	   100,0%	  
AVNRT	  
N	   0	   13	   0	   13	   0	   13	   13	  
%	  in	  group	   0	   100%	   0	   100%	   0	   100%	   100,0%	  
AVRT	  
N	   0	   2	   1	   1	   1	   1	   2	  
%	  in	  group	   0	   100%	   50%	   50%	   50%	   50%	   100,0%	  
Flutter	  
N	   3	   1	   4	   0	   0	   4	   4	  
%	  in	  group	   75%	   25%	   100%	   0%	   0%	   100%	   100,0%	  
Atrial	  
Tachycardia	  
N	   1	   2	   1	   2	   1	   2	   3	  
%	  in	  group	   33,3%	   66,7%	   33,3%	   66,7%	   33,3%	   66,7%	   100,0%	  
No	  
arrhythmia	  
induction	  
N	   0	   1	   0	   1	   0	   1	   1	  
%	  in	  group	   0%	   100%	   0%	   100%	   0%	   100%	   100,0%	  
VT/ectopics	  
N	   0	   7	   1	   6	   0	   7	   7	  
%	  in	  group	   0%	   100%	   14,3%	   85,7%	   0%	   100%	   100,0%	  
Total	  
N	   13	   6	   16	   25	   11	   30	   41	  
%	  total	   31,7%	   14,6%	   39%	   61%	   26,8%	   73,2%	   100,0%	  
Table 10. Patient’s preparation according to the indication for intervention. 
There were 2 cases of AF where the transseptal approach and TOE were not performed 
once the outcome was AV node ablation with implantation of single chamber pacemaker. 
Looking at the following chart 9, we can observe that the interventions for AF ablation 
took longer on average, followed by the interventions for AVRT, Atrial tachycardia and 
ventricular tachycardia/ectopy. In contrast, the interventions whose aim was to terminate 
the Flutter circuit took less time on average. AF, VT and AVRT are complex procedures 
and, therefore, also resort to three-dimensional mapping systems. 
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Chart 9. Procedure duration according to the underlying arrhythmia. 
On the other hand, atrial flutter and AVNRT are procedures with anatomical substrates 
that favour well designed and located arrhythmias. 
 
Procedure	  duration	  (minutes)	  
N	   N	  (%)	   Mean	  
Standard	  
Deviation	  
Minimum	   Maximum	  
Atrial	  Fibrillation	   9	   23,1	   204,667	   90,269	   100,00	   360,00	  
AVNRT	   13	   33,3	   118,846	   27,009	   85,00	   169,00	  
AVRT	   2	   5,1	   146,000	   79,196	   90,00	   202,00	  
Flutter	   4	   10,2	   85,500	   44,613	   46,00	   136,00	  
Atrial	  tachycardia	   3	   7,7	   140,667	   77,822	   55,00	   207,00	  
No	  arrhythmia	  
induction	  
1	   2,6	   92,000	   .-­‐	   92,00	   92,00	  
VT/ectopics	   7	   18,0	   142,429	   62,222	   60,00	   215,00	  
Total	   39	   100	   132,873	   63,522	   46,00	   360,00	  
Table 11. Relationship between the study diagnostic and the procedure duration. 
We can verify on the table 11 that the procedures for AF ablation lasted on average about 
3h30mins. On the opposite, the procedures for Atrial Flutter ablation had an approximate 
duration of 1h30mins, nearly less than half of the time. Just for curiosity, we also find that 
the longer procedure (AF) had the duration of 6 hours, while the shorter procedure (Atrial 
Flutter) had the duration of less than an hour. 
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Chart 10. Distribution of RF total time and number of applications according to underlying arrhythmia. 
In agreement with the average duration of procedures, we also find in the chart 10 that the 
time and number of radiofrequency energy used for ablation therapy is greater in cases of 
atrial fibrillation and posteriorly in atrial tachycardias. On the other hand, it is possible to 
observe that reentrant tachycardias are those that require less radiofrequency ablation, since 
the goal in these arrhythmic substrates is to destroy the viability of the accessory pathway, 
and once located, corresponds to a very limited area of intervention. 
 
 
The clinical practice in Pacing focused essentially on follow-up of devices, with observation 
and interrogation of pacemaker, ICDs and CRTs. The time allocated for each patient is 
about 20 to 30 minutes. Each device follow-up always begins by monitoring the patient 
with a 3 lead ECG in order to have a trace during the entire clinic (on a proper monitor 
placed for the purpose). In addition, a rhythm strip is always acquired before and after the 
interrogation of the PM (for documentation purposes). The device is then interrogated 
with the corresponding programmer, in order to obtain all the information contained in the 
device, but essentially the pacing and sensing thresholds, catheters impedances, battery 
voltage, total times of stimulation by the device, episodes of arrhythmia(s) and therapy 
deliveries in the case of an ICD. 
Any necessary changes or optimizations such as sensitivities, intervals, pacing or 
algorhythms adjustments are then performed (always considering the clinical history and 
state of the patient) and a further appointment is scheduled for continued monitoring of 
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the device (in 1, 3, 9 months post-implantation and then yearly for pacemakers; every 3 
months in case of ICD and CRT devices). If appropriate, the substitution of the generator 
is requested. Besides the interrogation, verification and optimization of the device, it is also 
a Cardiac Physiologist’s responsibility to take notice of the clinical condition of the patient 
and, if needed, refer him for a Cardiology review or Warfarin clinic, for clinical follow-up 
and optimization of medical therapy. 
In order to trace a drawing of the pacing clinic observed and performed in this internship, 
we examine some data such as: pacing clinic location, manufacturer, type of device, reason 
for implant, anomalies/dysfunctions identified, optimizations performed and prevalence of 
rate response on and pacing dependent patients. 
 
We have performed a total of 283 devices follow-up in individuals of both genders, 
predominantly in male subjects (64,3%). 
	   Age	  (years)	  
	   N	   N	  (%)	   Mean	  
Standard	  
Deviation	  
Minimum	   Maximum	  
Gender	  
Male	   182	   64,3	   72,110	   13,382	   25,00	   97,00	  
Female	   101	   35,7	   76,495	   14,378	   21,00	   97,00	  
Total	   283	   100	   73,675	   13,881	   21,00	   97,00	  
Table 12. Demographic characterization of the pacing sample according to gender and age. 
It is possible to verify by the analysis of table 12 that the mean age of the sample was 73 ± 
13.881 years, the younger subject was a female patient with 21 years and the older subjects 
were both male and female patients with 97 years of age. 
 
 
Chart 11. Distribution of devices follow-up according to location. 
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As stated earlier, the clinical practice in Pacing was divided between two sites, being the 
vast majority of the follow-ups performed at Harefield Hospital (n = 208) and a smaller 
number at the Luton and Dunstable Hospital (n = 75), once the first is a specialized 
hospital for Cardiology with two to three pacing clinics running daily, while the Luton and 
Dunstable Hospital is a district general hospital with a single pacing clinic running twice a 
week. 
 
Let us observe now a graph (chart 12) illustrating the characterization of the observed 
pacing clinics by type of device. 
 
Chart 12. Characterization of pacing sample according to type of device. 
We find that the majority of the follow-ups (66,8%) were performed in individuals with 
standard pacemakers, being the remaining third of follow-ups performed on other devices 
such as Reveal, ICD, CRT-P and CRT-D. 
 
Chart 13. Distribution of devices followed-up according to manufacturer. 
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We also verify by looking at chart 13 that the vast majority of devices were manufactured 
by Medtronic (including the Reveal devices). On the other hand, there were very few 
patients being followed in clinic with a Vitatron (n = 12) or Biotronik (n = 4) pacemaker. 
 
Once from the clinical point of view it does not add any supplementary information, we 
will no longer analyse and discuss the data related to Reveal devices, displaying only activity 
data regarding Pacemakers, ICD and CRT devices. 
 
 
Chart 14. Reason for implant of pacemaker. 
We can verify on the chart 14 that there is an equitable distribution between the four 
reasons for pacemaker implantation in our activity. On the other hand, when regarding 
indication for ICD implant, sustained VT + syncope (47,1%) was the main reason 
observed for the implantation of this type of devices (chart 15). 
 
 
Chart 15. Indication for implant of ICD. 
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Chart 16. Reason for implant of CRT device. 
Within the varied indications for Cardiac Resynchronization Therapy devices implantation, 
the presence of bradycardia with LV dysfunction (29,8%) and the occurrence of sustained 
VT associated with LV dysfunction (23,4%) were the two main reasons seen. 
 
On a general descriptive way, we can verify on the chart 17 that the vast majority of devices 
were programmed on DDD, followed by DDD with Rate-response on. On the other hand, 
devices programmed with pacing mode VDD or VDIR were rarely seen. 
 
Chart 17. Characterization of pacing sample according to type of device. 
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We can observe through the table 13 that were observed dysfunctions and optimization in 
all types of devices. It is also possible to verify that only 10% of the subjects presented with 
dysfunction of the device; the majority of the dysfunctions founded were increased 
threshold (n = 7), ventricular fusion (n = 5), undersensing (n = 4), diaphragmatic 
stimulation (n = 4) and dislocated lead (n = 3). 
	   Device	  dysfunctions	   Device	  optimizations	  
	   Yes	   No	   Yes	   No	  
PM	  
N	   18	   172	   51	   139	  
%	  no	  grupo	   9,5%	   90,5%	   26,8%	   73,2%	  
ICD	  
N	   3	   31	   12	   22	  
%	  no	  grupo	   8,8%	   91,2%	   35,3%	   64,7%	  
CRT	  
N	   6	   40	   16	   30	  
%	  no	  grupo	   13,0%	   87,0%	   34,8%	   65,2%	  
Total	  
N	   27	   243	   79	   191	  
%	  total	   10,0%	   90,0%	   29,3%	   70,7%	  
Table 13. Prevalence of device dysfunctions and optimizations. 
On the other hand, the device was optimized in 79 subjects, approximately a third of the 
cases (29,3%). The output was reprogrammed (either increased, reduced or changed in 
configuration) in 39 cases; the pacing mode was changed in 7 cases; the PVARP was 
extended in 3 cases; the Rate-response was switched on in 5 cases and sensivity was altered 
in 3 cases. 
	   Rate	  Response	   Pacing	  Dependent	  
	   Yes	   No	   Yes	   No	  
PM	  
N	   79	   111	   69	   121	  
%	  no	  grupo	   41,6%	   58.4%	   36,3%	   63,7%	  
ICD	  
N	   9	   25	   1	   33	  
%	  no	  grupo	   26,5%	   73,5%	   2,9%	   97,1%	  
CRT	  
N	   16	   30	   16	   30	  
%	  no	  grupo	   39,5%	   60,5%	   39,5%	   60,5%	  
Total	  
N	   104	   166	   86	   184	  
%	  total	   38,5%	   61,5%	   31,9%	   68,1%	  
Table 14. Prevalence of pacing dependent subjects and rate response on. 
Some patients experienced improvement in quality of life when the rate response 
algorhythm is switched on, whilst others do not feel much progress. However, has been 
increasingly used in daily practice. During the pacing clinic were observed 104 (38,5%) 
patients whose device had the rate response on. Finally, from all the patients observed in 
the pacing clinic, 86 subjects were pacing dependent (31,9%). 
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Chapter III 
SELECTED CLINICAL CASES 
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Clinical Case 1 
1. INTRODUCTION 
Despite Atrial fibrillation being by far the most common Supraventricular tachycardia seen 
throughout cardiac patients, the most common reentrant SVT seen is Atrioventricular 
Node Reentrant Tachycardia (NATALE et al., 2011). 
The precise anatomic site and nature of the pathways involved have not yet been 
established, and several attempts to provide a reasonable hypothesis based on anatomic or 
anisotropic models have been made. There has been considerable evidence that the right 
and left inferior extensions of the human atrioventricular node and the atrionodal inputs 
they facilitate may provide the anatomic substrate of the slow pathway, and a 
comprehensive model of the tachycardia circuit for all forms of AVNRT based on the 
concept of atrionodal inputs has been proposed. Still, however, the circuit of AVNRT 
remains elusive. 
AVNRT occurs in 50% to 60% of patients presenting with regular narrow complex 
tachycardia (NCT), ie, QRS duration < 120 ms, unless aberrant conduction, which is 
usually of the right bundle branch type, or a previous conduction defect exists. 
Tachycardia-related ST depression and RR interval variation may be seen. It is more 
frequent in women than men (2:1) and may first present with recurrent palpitations at any 
age, although most commonly between 30 and 50 years (KATRITSIS & CAMM, 2010). 
 
2. PRESENTATION 
A female patient, 65 years, was referred by the Consultant Cardiologist of a district general 
hospital with a history of palpitations and some episodes of dizziness. Symptoms slightly 
improved with flecainide. A 24 hours tape performed in January 2013 showed an episode 
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of what looks like AVNRT, although non-sustained, with possible short RP and a jump at 
the point of initiation of the tachycardia. 
The patient was later admitted to the Accidental & Emergency Department of other 
general hospital in the same month of January and the ECG recorded showed tachycardia 
at 206 bpm, which was terminated with adenosine. The transthoracic echocardiogram 
showed no structural heart disease and good left ventricular systolic function. 
 
The procedure was initiated by monitoring the patient to the polygraph and the 
monitor/external cardioverter. Patient monitoring included the placement of electrodes to 
obtain the 12 electrocardiographic leads and the placement of a paddle in the dorsal area of 
the patient to work as a return for RF generator.  
The multidisciplinary team was composed by one interventional Electrophysiologist, two 
Cardiac Physiologists, a Radiographer, a nurse and myself, as an intern. 
The four diagnostic catheters selected for the performance of the procedure were: two 
quadrapole catheters of Bard Electrophysiology, Viking 6F model, length 115 cm (for HRA 
and RV); one decapole catheter of Bard Electrophysiology, Dynamic 6F model, length of 110 
cm and tip of 2 mm (for Coronary Sinus); and one quadrapole catheter (specially shaped 
"His hugger") of St. Jude Medical, Supreme CRD-2 6F model with a length of 120 cm (for 
His). Regarding the ablation, it was selected the quadrapole ablation catheter of Biosense 
Webster, Celsius 7F model with 115 cm of length and tip of 4 mm. 
The catheters were introduced using the Seldinger technique through the right and left 
femoral veins and placed in the traditional position mapping: 
- HRA: placed either in the right atrial appendage (RAA) or on the laterall wall of the RA, 
registering the atrial activation sequence; 
- His: seated across the AV junction at the top end of the Triangle of Koch; 
- CS: placed through the CS ostium (which arises in the right atrium at the bottom corner 
of the Triangle of Koch) in the coronary sinus, the perfect conduit around the AV groove 
of the left Atrium and Ventricle, making it possible to record the electrical activity on the 
left side of the heart; 
- RV: positioned in the RV apex. 
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The baseline ECG prior to the procedure showed sinus rhythm with heart rate of 92 bpm. 
The following intervals were measured: PR = 136ms; QRS = 84ms; QT = 396ms. 
Figure 10. 12 lead baseline ECG showing sinus rhythm with a ventricular rate of 92 bpm. 
Following the setting of the diagnostic catheters in the correct positions, we obtained the 
following intracardiac electrogram, which shows a normal depolarization sequence of the 
cardiac conduction system. 
 
 
 
 
 
 
 
 
 
Figure 11. Intracardiac recordings taken at baseline. 4 leads surface ECG (I, aVF, V1, V6), 2 bipolar 
recordings from the high right atrium (HRA), 3 bipolar recordings from the His bundle region (distal = 
HISd, intermediate = HISm and proximal = HISp), five bipolar recordings from the coronary sinus (CSp = 
proximal, CS 7-8, CS 5-6, CS 3-4, CSd = distal); 1 bipolar recording from the RV apex (RVp). 
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The study started with pacing from ventricles to assess the retrograde properties of the 
heart conduction system. With a drive train of 600 ms and an extra-beat of 290 ms, we 
registered a VA prolongation of greater than 50 ms over an S2 decrement of 10 ms, this is 
defined as VA jump. In the retrograde limb, it is possible to see that VH prolong which is 
indicative of infra-hisian decrementation or block, but in this instance there was no change 
in VH time suggesting the existence of dual AV nodal physiology.  
Figure 12. Intracardiac recordings taken during programmed ventricular stimulation. (left) With a 
coupling interval of 300 ms the VA interval is 126 ms and (right) with a coupling interval of 290 ms it 
suddenly increased to 208 ms. 
An ectopic induced a NCT with VA time of 110 ms post-catheter insertion. Onset 
suggestive of AVNRT and not AT, but non-sustained and no diagnostic maneuvers were 
possible. Of interest, earliest A in prox-mid CS which lends evidence to AVNRT.  
 
 
 
 
 
 
 
 
 
Figure 13. Intracardiac recording showing the NCT initiated by catheter-induced atrial ectopic. 
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Figure 14. Intracardiac recording showing termination of tachycardia with a V-A-V response. 
CS activation during the tachycardia remained consistent to that of the retrograde curve 
with CS 7-8/5-6 leading, indicative of a circuit involving the AV node/triangle of Koch 
area. Due to CS 7-8 leading, we elected to do parahisian pacing to assess the nodal 
response in attempt to identify the presence of an accessory pathway. 
 
 
 
 
 
 
 
 
 
 
Figure 15. Intracardiac recording showing parahisian pacing. Response indicative of nodal conduction. 
After parahisian pacing, we moved to investigate the anterograde refractory period. This 
was done with a drive train and shortening S2 extras. During the anterograde curve, we saw 
a prolongation of the AH interval greater than 50 ms over decrement of S2 by 10 ms.  
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During atrial testing, after the jump had occurred, we saw that there were incidences where 
the atrium was depolarized retrogradely, seemingly related to our paced extra. When this 
occurs with a consistent pattern then this is termed an “echo”. In this study, during the 
ARP we saw these on multiple occasions. The pattern showed a short VA time, which is 
consistent with a typical echo seen with dual node physiology. Due to inability to induce 
the tachycardia, we used single and double sensed extras and, again, we were able to 
reproduce single echoes easily. 
 
 
 
 
 
 
 
 
Figure 16. Intracardiac recordings taken during programmed atrial stimulation showing an AH jump. 
 
 
 
 
 
 
 
 
 
 
Figure 17. Intracardiac recordings taken during programmed atrial stimulation from CS with single 
sensed extra with a short VA return time. 
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Following the inability to induce tachycardia, we administered isoprenaline. This failed to 
induce any tachycardia and therefore atropine was also tried. 
Following both administrations of medication, we ran full EP maneuvers in order to test 
these effects on cardiac electrophysiology. 
During these EP tests, we had two episodes of a 1:1 broad complex tachycardia (BCT) with 
LBBB aberrancy; short atrial entrainment consistent with an atrial reciprocating 
mechanism, i.e. not VT. CS activation also consistent with previous findings of nodal 
mechanism. 
Figure 18. Intracardiac recordings taken during programmed stimulation with an infusion of 
isoprenaline IV showing induction of sustained broad complex tachycardia with LBBB aberrancy, VA 
association and relatively short VA time (cycle length = 240 ms).  
During BCT, some ventricular entrainment was attempted however this pacing terminated 
tachycardia on first non-fused QRS without atrial capture (figure 19), again suggestive of an 
atrial mechanism and lending evidence to the lack of an accessory pathway. 
Although the tachycardia itself was not proven to be AVNRT, we were able to suggest that 
this mechanism was not mediated by an accessory pathway, and the consistency of 
induction, termination and response to pacing was unlikely to be an AT. The BCT was 
proven not to be VT and in the light of the patient incessant tachycardia, the most likely 
diagnosis was AVNRT, with a slightly atypical pattern, with retrograde conduction via slow 
pathway and anterograde conduction via the fast pathway. 
In this situation, and due to the relative risk to the patient of AV node damaged, the case 
was discussed with another Electrophysiologist and there was reasonable evidence to offer 
slow pathway ablation in the view of highly symptomatic status. 
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Figure 19. Intracardiac recordings showing tachycardia termination with entrainment. 
The radiofrequency was delivered on the slow pathway site but was stopped on a first 
attempt due to ventricular ectopics and few rapid junctional beats. Eventually, during 
ablation the patient showed a stable junctional rhythm, indicative of ablation around the 
slow pathway and therefore, 60 seconds was delivered at this site.   
 
 
 
 
 
 
 
 
 
Figure 20. Intracardiac recordings during RF delivery with induction of few rapid junctional beats. 
 
After the delivery of radiofrequency, a retest was performed and a bidirectional slow 
pathway block was confirmed. 
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Figure 21. Intracardiac recordings taken during ventricular stimulation showing VA block. 
 
There were no complications registered during the procedure. It was considered a 
successful RF ablation procedure. Slow pathway block was showed and tachycardia was 
non-inducible at the end.  Non-sustained HRA-leading atrial tachycardia was also induced 
on few occasions, however of uncertain clinical relevance hence not mapped. 
The patient was discharged with the usual pharmacological therapy and informed to 
contact the Cardiac Department in case of recurrence. 
 
3. DISCUSSION 
Catheter ablation of AVNRT is highly successful with minimal complications: the main 
one being inadvertent damage to the compact AV node and/or conduction system leading 
to heart block and the need of permanent pacemaker implantation in approximately 0.5 – 
1% of patients. Modification or complete ablation of the slow AV nodal pathway has a 
“cure” rate of about 95%, so these patients can stop their drugs with confidence. 
AVNRT has been traditionally classified as slow-fast or typical AVNRT, and fast–slow or 
atypical AVNRT, according to the conventional description of dual AV junctional 
pathways. The fast pathway of the reentry circuit runs superiorly and anteriorly in the 
triangle of Koch, whereas the slow pathway runs inferiorly and posteriorly close to the CS 
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ostium. Indeed, in the majority of slow–fast cases of AVNRT, the site of the earliest atrial 
activation is close to the apex of Koch’s triangle, near the AV node-His bundle junction, 
i.e. anterior to the AV node. In the fast–slow form, the site of the earliest atrial activation is 
usually recorded posterior to the AV node near the orifice of the coronary sinus. 
Considering this, and although AVNRT represents the most common paroxysmal SVT in 
the human and has a successful rate of treatment by ablation with minimal complications, 
several questions and obscure points remain. This old model of the reentrant circuit 
comprised two anatomically distinct limbs confined to the AV node can provide 
explanations for many aspects of the electrophysiological behaviour of these tachycardias. 
However, these pathways have not been demonstrated histologically and, despite several 
attempts to provide a reasonable model based on anatomic or functional anisotropic 
characteristics, the exact circuit responsible for the reentrant tachycardia is unknown. 
Nevertheless, it is now known that discontinuous refractory periodic curves may not be 
present in all patients with AVNRT. Anterograde dual pathways are demonstrable in 75% 
of patients with tachycardia, and AVNRT may occur in the presence of continuous AV 
nodal conduction curves. Conversely, anterograde dual pathways can be demonstrated in 
subjects without tachycardia (KATRITSIS & CAMM, 2006). 
It is now becoming evident that fast–slow AVNRT may be of the (usual) posterior, 
anterior, and middle type according to the mapped location of the retrograde SP. 
Previous studies have reported on a posterior (or type B) variety of presumed slow–fast 
AVNRT, with long ventriculoatrial intervals and the earliest retrograde atrial activation near 
the coronary sinus ostium. Posterior fast pathways have been reported in up to 6% of 
patients with AVNRT. Eccentric retrograde atrial activation of the fast–slow as well as the 
slow–slow forms has also been reported. HWANG et al. (1997) reported that the earliest 
retrograde atrial activation was recorded within the CS in 0% (0/310 patients) among 
typical form and in 43% (20/46 patients) among atypical form, while NAM et al. reported its 
incidence of 6% (3/52 patients) among typical form and 80% (8/10 patients) among 
atypical form. CHEN et al. reported its incidence of 8% (16/211 patients) among typical 
form and 14% (2/14 patients) among atypical form.  
Others observations should be considered as the inferior nodal extensions model of the 
AVNRT circuit. The inferior nodal extensions are basically part of the AV node and 
facilitate atrial inputs that also contain transitional cells connecting atrial myocardium with 
the nodal extensions. They have been proposed as the anatomic substrate of the slow 
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pathway. Recent studies have shown that extrastimuli delivered at the left inferoparaseptal 
area, close to the His bundle, may reset the AVNRT probably by engaging the left inferior 
nodal extension. Additionally, JACKMAN et al. reported that the leftward posterior nodal 
extension constituted the retrograde limb of the reentrant circuit and the SP ablation at the 
earliest retrograde activation site within the proximal CS was, therefore, required to 
eliminate atypical AVNRT with the eccentric CS activation pattern. Conversely, others 
postulated that the retrograde left-sided atrionodal connection was an innocent bystander; 
therefore, conventional right-sided SP ablation was sufficient to eliminate inducibility of 
atypical AVNRTs with the eccentric CS activation pattern (NATALE et al., 2011). 
Therefore, this makes the diagnosis and classification of the arrhythmia more complicated 
and sometimes impossible to identify a single AVNRT form, as various AVNRT types 
could be explained on the basis of variable anatomical characteristics and orientation of 
these extensions.  
 
The pattern of conduction as well as the incessant nature seen in patients with the fast–
slow form of AVNRT can also be seen in atrioventricular reentrant tachycardia due to the 
presence of concealed septal accessory pathways with decremental properties. And in 
certain cases of fast–slow or slow–slow AVNRT, retrograde activation is even suggestive 
of a left lateral accessory pathway. Thus, in the presence of a narrow QRS tachycardia, 
AVNRT should also be differentiated from atrial tachycardia or orthodromic 
atrioventricular reentrant tachycardia due to an accessory pathway. 
AVNRT VS. ATRIAL TACHYCARDIA 
Demonstration of change in AA interval when a ventricular extrastimulus is delivered 
during tachycardia, tachycardia termination by a ventricular extrastimulus that did not 
conduct to the atrium, constant His-atrial interval of the return cycle after introduction of a 
premature atrial impulse with a wide range of coupling intervals during tachycardia, and 
demonstration of ventricle to atrium to His sequence during retrograde initiation of 
tachycardia indicate aetiology other than atrial tachycardia. The difference in the AH 
interval between atrial pacing and the tachycardia may also allow differentiation of atypical 
AVNRT from other types of long RP tachycardias. A variation of AH > 40 ms indicates 
AVNRT, whereas in patients with AVRT due to septal pathways or AT these differences 
are < 20 and 10 ms, respectively. Finally, the difference of the post-pacing interval and the 
tachycardia cycle length, as described by Michaud et al., may also be of help. 
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AVNRT VS. AVRT DUE TO SEPTAL ACCESSORY PATHWAYS 
The eccentric retrograde atrial activation during ventricular stimulation or tachycardia and 
the demonstration of continuous AV or VA conduction curves usually characterizing non-
septal concealed accessory pathways differentiate this form of atrioventricular reentry from 
AVNRT. However, AVNRT is now known to occur with eccentric atrial activation and, in 
addition, decremental septal pathways may mimic AVNRT especially of the fast–slow or 
slow–slow forms. Septal pathways may have the property of decremental conduction and 
normal atrial retrograde activation during tachycardia. 
In case of relatively delayed retrograde conduction that allows the identification of 
retrograde P waves, ECG criteria can be applied for diagnosis. The presence of a pseudo-r’ 
wave in lead V1 or a pseudo-S wave in leads II, III, and aVF has been reported to indicate 
anterior AVNRT with an accuracy of 100%. A difference of > 20 ms in RP intervals in 
leads V1 and III was indicative of posterior AVNRT rather than AVRT due to a 
posteroseptal pathway. The documentation of pre-excited beats as well as AV dissociation 
and the induction of bundle branch block during tachycardia may assist the differential 
diagnosis. The demonstration of AV block or AV dissociation during tachycardia is 
characteristic of AVNRT excluding the presence of an accessory pathway. Similarly, the 
development of bundle branch block either spontaneously or after introduction of 
ventricular extrastimuli during AVNRT does not change the AA or HH intervals. A 
significant change in the VA interval with the development of bundle branch block is 
diagnostic of orthodromic AVRT and localizes the pathway to the same side as the block. 
 
In summary, AVNRT types are classified as typical (slow–fast) and atypical (fast–slow and 
slow–slow), according to the ratio of atrial-His/His-atrial intervals, the VA interval 
measured on the His bundle and high right atrial electrograms, and the site of the earliest 
retrograde atrial activation. However, variable sites of retrograde atrial activation have been 
described for all types of this arrhythmia. Therefore, several electrocardiographic and 
electrophysiological criteria and manoeuvres such as identification of retrograde P waves 
on the ECG, development of AV or bundle branch block, his-synchronous ventricular 
extrastimulation, AH interval, VA conduction indices or retrograde conduction are 
essential and have to be carefully used for differential diagnosis of narrow complex 
tachycardias, essentially with atypical characteristics. 
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Clinical Case 2 
1. INTRODUCTION 
Ventricular tachycardia - in contrast to most supraventricular arrhythmias, is serious and 
life threatening. These arrhythmias are most common shortly after acute myocardial 
infarction but they also occur remote from AMI and in young individuals with apparently 
normal hearts in whom the prevalence is approximately 0.1% of population. Patients who 
have experienced ventricular arrhythmia or who are at risk of ventricular arrhythmia require 
careful expert clinical assessment by an Electrophysiologist. Patients require treatment of 
their underlying heart condition and risk stratification for the development of future life-
threatening arrhythmia. Patients at high risk of this arrhythmia usually require an 
implantable cardioverter defibrillator. Ablation therapy is used increasingly in the 
management of patients with ventricular arrhythmia and may be used as the primary 
treatment (usually in patients with a normal or near normal heart) but in patients with 
structural heart disease it is usually adjunctive therapy to an ICD. Patients who experience 
repeated ICD shocks due to recurrent VT suffer a high level of morbidity and VT ablation 
is also valuable in the management of this patient group. 
 
2. PRESENTATION 
March 2011 
Asian male patient with 58 years referred by the Consultant Cardiologist of a district 
general hospital with some non-sustained VT on an Holter recording and a QRS of just 
about 120 ms on resting ECG. Known background of non-ischemic dilated 
cardiomyopathy, severe left ventricular dysfunction, normal coronary arteries and asthma.  
Patient refers an exercise tolerance around 100 yards on the flat and he can manage stairs 
without stopping, though these are an effort. No orthopnea described but paroxysmal 
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nocturnal dyspnea (PND) was present in the past. Considering his history, the decision to 
implant a CRT-D was made and this device was implanted in March 2011. 
 
Pacing clinic :: July 2011 
On the pacing clinic for a 3 months follow-up, the device trends show biventricular pacing 
only 88% of the time, frequent ventricular ectopics, couplets, triplets and a five beat Salvo. 
Initially, the patient did feel some improvement after the CRT-D implanted, although he 
does feel his breathlessness has returned (no PND, peripheral edema, dizziness or chest 
pain reported). Discussed with Consultant Cardiologist who felt that his ectopic frequency 
was contributing to his breathlessness and also the fact that he was not in biventricular 
pacing 100% of the time. Bisoprolol taken increased to 7.5 mg. 
 
Cardiology clinic :: November 2011 
Patient became more breathless and describes episodes of PND and breathless on minimal 
exertion. It was seen in pacing clinic showing heavy ectopic burden (despite increased 
Bisoprolol). The team decided to initiate Amiodarone. 
 
Pacing clinic :: November 2012 
On the yearly pacing clinic follow-up, patient presented with increased breathlessness at 
rest and ankle oedema lasting for 2 weeks. The device readings showed his premature 
ventricular contractions (PVC) count had risen from 7% to 12% more recently, which was 
impeding the proper function of the CRT device. 
 
Arrhythmia clinic :: December 2012 
Although his biventricular pacing initially was beneficial for his symptoms, it seems that 
after a first few months it plateaued and he was now back in NYHA class III functional 
status. His biventricular pacing percentage had been consistently suboptimal below 90%, 
mainly due to heavy burden of ventricular ectopic activity as well atrial fibrillation. Going 
through his 12 lead ECG, he had at least 2 different morphologies of ventricular ectopics, 
both coming from RV and LV outflow tract. 
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The patient decided to firstly try the spironolactone and see if this could improve his 
symptoms and then he would reconsider the invasive options. 
 
EP clinic :: February 2012 
From ECG monitoring and exercise test it was clear that he had at least 2 types of outflow 
tract-type ectopy, one possibly originating from the aortic cusps on the left side, and the 
other likely being from the high RVOT. 
Patient was then listed for outflow tract ventricular ectopy ablation as the ectopy burden 
had increased with a drop in biventricular pacing once more. 
 
 
The procedure began by monitoring the patient to the polygraph, the monitor/external 
cardioverter and to the Carto navigation system. Patient monitoring included placing 
electrodes for obtaining 12 electrocardiographic leads; a paddle in the dorsal area of the 
patient to act as a "return" for RF generator and a specific Carto 3 electrodes kit. 
This navigation system enables viewing of conventional catheters in real time, without 
exposure to X-ray radiation. Also allows to view the points of the heart where RF energy is 
applied, using them to create a three-dimensional geometry of the heart. 
The multidisciplinary team was composed by one Interventional Electrophysiologist, two 
Cardiac Physiologists, a Radiographer, a nurse and myself, as an intern. 
The diagnostic catheter selected to perform the procedure was one quadrapole catheter of 
Bard Electrophysiology, Viking 6F model, length of 115 cm (for RV). Regarding the ablation, it 
was selected the ThermoCool SmartTouch bi-directional navigation catheter of Biosense Webster, 
8F model with 115 cm of length and tip of 3,5 mm. 
 
The baseline ECG shows sinus rhythm with monomorphic ventricular ectopy. An 
assessment of the origin of the ectopy based on the prior and present ECGs confirms the 
suspicion of probable RVOT and/or Aortic cusp origin (figure 22). There was also the 
suspicion that one of these morphologies was fusion with intrinsic QRS. 
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Figure 22. Baseline 12 leads ECG with clinical ectopy. 
 
We begin the procedure by attempting pace mapping in the RVOT. The ECG below 
shows the danger of undersensing during pacing. 
Figure 23. Attempted pace mapping with good match but non-sustained VT with undersensed pace on. 
 
Some ventricular ectopics showed early map signal on the ablation catheter. Pacemapping 
was then attempted and a good RS match was seen (figure 24). 
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Figure 24. Early map signal seen with ventricular ectopics; then pacemapping with good RS match. 
 
 
 
 
 
 
 
 
Figure 25. Surface ECG and intracardiac signs showing earliness of map to RS in RVOT. 
We attempted ablation and some clinical ectopy was seen during RF. However, this failed 
to decrease the ectopic burden (figure 26). 
Considering this, we then move to the LV, targeting LVOT and Aortic root. A Carto 
geometry was created of the aortic root and the high portion of the LVOT. Extensive 
mapping done in Aortic root between RCC and LCC, being difficult to capture for 
pacemapping but early signals seen during clinical ectopy. Some RF ablation performed in 
this area with some increase in clinical ectopy seen during ablation but the ectopic burden 
remained high (figure 27). 
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Figure 26. Surface ECG showing clinical ectopy during RF ablation. 
 
 
 
 
 
 
 
 
 
Figure 27. Onset of ablation with spontaneous clinical VE. 
 
Following some ablation the decision was taken to perform an angiogram of the coronary 
sinus in order to see if there was a venous branch, which might allow us to map the 
epicardial surface of this area. The angiogram showed a large anteroseptal branch and the 
ablation catheter was manipulated into this vein. Pacemapping and early signal 
interpretation showed the earliest ablation signal during clinical ectopy. 
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Figure 28. Surface ECG and CS map signal showing early signal on map during ectopic (caliper shows 
map 14 ms pre QRS). 
 
There was also an excellent pacemap in this distal CS area and therefore RF was applied at 
this site. In order to perform RF ablation in CS, we changed the RF settings for 25 W with 
a high flow of 30 ml/min. 
 
 
 
 
 
 
 
 
 
Figure 29. Surface ECG and intracardiac signals showing pace map from CS. 
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Figure 30. Three-dimensional geometry showing the distal CS and its proximity to the Aortic root and 
LVOT (left). Local activation map showing early signals in Aortic root (right). 
 
It was performed 3 ablations attempts in each identified origin focus suppressing the 
ectopy.  
Figure 31. Three-dimensional geometry showing the sites of ablation (red spots) on the left. 3D 
geometry showing bipolar map with exit of ectopy on scar border (right). 
 
There was stable sinus rhythm thereafter and this presentation remained for 20 minutes 
after the RF application (figure 32). 
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Figure 32. Final surface ECG with no ectopy, 20 minutes after RF application. 
 
In the rhythm strips below we can see the difference in ectopy frequency prior and post-
procedure, allowing us to considerate successful ablation of VEs from proximal anterior 
interventricular vein opposite Aortic root, accessed via CS. 
 
 
 
 
 
 
 
Figure 33. Baseline rhythm strip at 6mm/s showing frequency of ectopy (left). Case end with rhythm 
strip at 6mm/s showing corresponding lack of ectopy (right). 
 
Patient was discharge and was seen 6 months later in EP clinic. The patient has been 
feeling much better with far less ectopics than before. His ECG showed reasonably 
frequent OT ectopics with similar morphology to previous, sometimes in couplets. 
However, there has been clinical improvement with evidence of reduced ectopic burden via 
his pacing check. 
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3. DISCUSSION 
Ventricular premature contractions originating in the right ventricular outflow tract are 
often associated with triggered or reentry mechanisms but may more rarely be related to 
increased automaticity. These individuals are usually symptomatic, with great impact on 
their quality of life, and they often exhibit refractoriness to the pharmacological therapy.  
The region of RVOT and LVOT is the most common origin of VT and PVCs, accounting 
for approximately 10% of all patients referred for evaluation of VT. More than 70–80% of 
these arrhythmias originate from the RVOT. Other origins include the pulmonary artery, 
near the bundle of His, the LVOT, the aortic sinuses of Valsalva, the coronary sinus and 
cardiac veins, the mitral and tricuspid valve annuli, and the epicardium. 
The focal VT origin can be identified from activation and/or pace mapping. Although 
activation mapping is the strategy of first choice, pace mapping can be used to identify a 
region of interest and then refine position based on activation, and can be the major guide 
to the ablation site when spontaneous arrhythmia is infrequent. Pace mapping should be 
done at the VT rate. The site where pacing exactly reproduces the 12-lead ECG of the 
spontaneous or induced VT should be sought. The spatial resolution of pace mapping is 
limited and in some patients a perfect pace map is seen at sites up to 2 cm away from the 
VT origin. Pacing at stimulus strengths only slightly greater than threshold is desirable to 
avoid capture over a large area that may reduce accuracy. 
More and more labs are using three-dimensional electroanatomical mapping systems to 
assist in relating the anatomy to the mapping data. The development of this technology has 
shown great ability to identify the focal point of origin of the ectopy. The point of 
activation is determined as the earliest point with respect to the beginning of the QRS 
complex. In unipolar mapping there is a QS morphology with rapid deflection in the 
electrogram. The point of origin is thus identified before the propagation of the activation 
wave. In the RVOT, bipolar electrograms typically have normal amplitude (e.g., 1.5 mV) 
and are sharp, without fragmentation. Activation at the site of successful catheter ablation 
precedes the onset of the surface QRS complex by 10 to 60 ms. The bipolar electrogram 
may display high-frequency low-voltage activity preceding the main local ventricular 
electrogram component (ALIOT et al., 2009). 
The successful ablation of ectopy in the RVOT using three-dimensional mapping systems 
is described to be above 80% and with no recurrence. There a few important factors to be 
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considered: the RF application reduced to the point of activation; the reduced use of 
fluoroscopy and the ability to identify more than one early activation point (regardless of 
their proximity), which with conventional mapping would have been difficult to identify 
(INFANTE et al., 2011). 
There are no controlled or multicentre trials of ablation. In reported case series, acute 
success rate of RF catheter ablation of RVOT-VT is 65–97% and typically exceeds 80%; 
recurrence of arrhythmia has been reported in up to 5% after acutely successful ablation. 
Failure is usually due to inability to induce the arrhythmia for mapping. Complications are 
rare, but perforation and tamponade are reported and ablation of foci near the His bundle 
region can result in heart block. 
Radiofrequency ablation with solid 4 mm tip electrodes at maximal temperatures of 50ºC – 
70ºC and power settings of 50W is usually sufficient when mapping is adequate. Use of 8 
mm electrodes with higher power or irrigated electrodes is usually not necessary; avoiding 
steam pops from high-power ablation is particularly desirable to avoid perforation when 
ablation is performed in the RVOT, once its leftward posterior aspect is only 4 mm from 
the left main coronary artery and therefore that is a theoretical risk of coronary artery injury 
with ablation. 
 
Sustained monomorphic ventricular tachycardia (SMVT) is not common in non-ischaemic 
dilated cardiomyopathies but 80% of those that occur are due to scar-related reentry, with 
the remainder due to bundle branch reentry or a focal origin. Scars are probably due to 
progressive replacement fibrosis. Compared with post-infarction VT, areas of scar are 
smaller, but patients who present with SMVT typically have multiple morphologies of VT 
inducible. Magnetic resonance imaging with delayed Gd enhancement and voltage mapping 
demonstrates that scars are often adjacent to a valve annulus. Transmural scar is rare and 
intramural scars are common. These features likely account for the general perception that 
ablation of VT is more difficult when compared with that in the post-MI population. When 
endocardial ablation fails, epicardial mapping usually shows that more extensive scar is 
present in the epicardium (ALIOT et al., 2009). 
The following data is from a few single-centre studies. In a series of 19 patients with 
recurrent SMVT due to dilated cardiomyopathy, endocardial ablation abolished all 
inducible VT in 14 patients. After a follow-up of 22 months, five patients were alive 
without VT recurrence. In a series of 22 patients, epicardial mapping and ablation was 
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performed if endocardial ablation failed. Scar-related reentry circuits were identified in the 
endocardium in 12 patients and in the epicardium in all 7 who underwent epicardial 
mapping after failed endocardial ablation. At least one VT was abolished in 16 of 22 
patients and all VTs were abolished in 12 of 22 patients. During a mean follow-up of 334 
days, VT recurred in 46% of patients, one patient died of heart failure, and cardiac 
transplantation was performed in two patients. 
Ablation can be life-saving in patients with incessant VT or VT storm. In these small series, 
no serious complications were reported, although septal ablation produced anticipated AV 
block in one patient (ALIOT et al., 2009). 
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